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CHAPTER 1: BACKGROUND AND SIGNIFICANCE 
Background of the Study 
Chronic Kidney Disease (CKD): Definition, Stages and Prevalence 
CKD is a debilitating disease of the kidneys characterized by a gradual loss of kidney 
function ranging from months to years. The loss in kidney function is evident from reduction in 
the urine production rate from the kidneys, also known as glomerular filtration rate (GFR). CKD 
is classified to five stages based on GFR values and the albumin creatinine ratio.  These five stages 
are shown in Table 1. The last stage of CKD, Stage G5 is also known as End Stage Renal Disease 
(ESRD). 
Table 1  
Stages of CKD 
Stage of CKD GFR (ml/minute/1.73m2) 
G1 ≥ 90 
G2 60-89 
G3a 45-59 
G3b 30-44 
G4 15-29 
G5 <15 
Note. Adapted from Kidney Disease Statistics for the Unite States, 2016. 
GFR-Glomerular filtration rate, ml/minute/1.73m2- milliliters per minute 
per 1.73 meters square. 
Stage G5 CKD has a GFR of < 15 ml/minute/1.73m2. While Stages G1 to G3 are mostly 
asymptomatic, Stages G4 and G5 are the most disturbing stages with innumerable symptoms and 
complications (“Kidney Disease Statistics for the United States,” 2016). In Stage G5 CKD, the 
individual becomes dependent on various renal replacement therapies including hemodialysis 
(HD), peritoneal dialysis (PD) or kidney transplantation to sustain his/her life (Daugirdas, Blake, 
& Todd S., 2015). 
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CKD affects nearly 31 million people in the US  and the most common causes of ESRD 
are diabetes and hypertension (“Kidney Disease Statistics for the United States,” 2016). The 
prevalence of CKD is 15 percent and there are 726,331 cases of ESRD in the U.S. population  
(“Annual Data Report Highlights,” 2018). CKD is the 9th leading cause of death in the US, and 
has a high incidence of premature death (“Kidney Disease Statistics for the United States,” 2016). 
Almost 63.1% of all patients with ESRD were receiving HD whereas 7% were treated with 
PD, and 29.6% had a kidney transplantation (“Annual Data Report Highlights,” 2018). HD therapy 
involves filtration of blood across a membrane filter called dialyzer, and the individual is 
connected to a machine at a dialysis unit or at home. The blood is filtered across the membrane 
and various waste products from a person’s blood shift to the other side of the dialyzer membrane 
where dialysate is present. These waste products include urea, creatinine, potassium and extra fluid 
that is accumulated in the blood. Individuals on HD must be dialyzed 2 to 3 times weekly to get 
rid of the waste products and fluids in their body (Daugirdas et al., 2015). 
Fatigue in Stages G4 and G5 CKD 
Multiple symptoms are reported by individuals suffering from CKD, particularly in the 
advanced stages. Almost 30 symptoms have been reported in individuals with CKD with the 
common ones including fatigue (81%), drowsiness (75%), pain (65%), pruritus (61%), and dry 
skin (57%) (Almutary, Bonner, & Douglas, 2016). Amongst these symptoms, fatigue is one of the 
most bothersome, distressing, troublesome and a major source of stress in the past studies 
conducted in individuals with advanced CKD (Almutary, Bonner, & Douglas, 2013; Biniaz, 
Tayybi, Nemati, Shermeh, & Ebadi, 2013; Horigan, Schneider, Docherty, & Barroso, 2013; Jhamb 
et al., 2013). The reported prevalence of fatigue ranges from 60-97% in individuals with Stage G5 
CKD (Horigan, 2012), and 70-97% in Stage G4 and Stage G5 CKD (Bonner, Caltabiano, & 
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Berlund, 2013; Bossola, Vulpio, & Tazza, 2011). Almost 56% of individuals on HD reported 
suffering from severe fatigue (Bayumi, 2015). 
Almost 94% of individuals on HD reported that they would accept more frequent HD if it 
would increase their energy, which indicates that fatigue is important to individuals on HD (Jhamb 
et al., 2013). In fact, the prevalence of fatigue in dialysis individuals is higher than the general 
population (Artom, Moss-Morris, Caskey, & Chilcot, 2014). Investigators found fatigue being 
cross loaded on five symptom clusters in Stage G5 CKD individuals that confirms the pervasive 
nature of fatigue (Almutary, Douglas, & Bonner, 2016). 
Fatigue is a multidimensional and multifactorial concept with poor outcomes that 
encompasses an individual’s personal, professional and social life (Ream & Richardson, 1996). 
Individuals with CKD describe fatigue as a subjective, unpleasant, distressing experience 
associated with generalized feelings of tiredness and exhaustion (Artom et al., 2014). Fatigue is 
multidimensional; various aspects such as physical, cognitive and affective components are 
involved. In ‘physical fatigue’ there is physical discomfort and the patient feels ‘feeble, dizzy and 
tired’ (Lee, Lin, Chaboyer, Chiang, & Hung, 2007) and is exhausted (Horigan et al., 2013). 
‘Affective fatigue’ causes emotional reactions like ‘feeling bad’, ‘being upset,’ and ‘cognitive 
fatigue’ causes ‘difficulty in paying attention’ or ‘difficulty in keeping eyes open’ and ‘difficult to 
concentrate’ (Lee et al., 2007), ‘difficulty in remembering names’ and ‘difficulty in participating 
in conversations’ (Horigan et al., 2013). Among all the types of fatigue described above, 
individuals on HD in Taiwan reported ‘affective fatigue’ the most (Lee et al., 2007).  
Other multidimensional aspects of fatigue include ‘quality,’ ‘distress,’ ‘timing,’ and 
‘severity.’ Temporal patterns were studied using a qualitative approach in 14 individuals on HD 
over a 36-hour period from one HD session to the evening before the next session. Participants 
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reported continuous fatigue and a spike of fatigue after dialysis (Horigan & Barroso, 2016). 
Limited research is available on the ‘quality’ of symptom fatigue in individuals with CKD, in that 
fatigue has been described by different words such as ‘feeling exhausted,’ ‘weak,’ ‘tired,’ and 
having ‘insufficient energy (Lee et al., 2007)’. The ‘severity’ of fatigue has been reported in 
various studies that used the Fatigue Severity Scale in individuals on HD, in that severe fatigue 
was reported in almost 56% of individuals on HD (Bayumi, 2015). Jhamb et al. (2013) reported 
profound levels of fatigue in 86 individuals with Stage G5 CKD. Patients after dialysis had severe 
fatigue that averaged 3.4 ± 1.2 (severity scale from 1 to 5, worst) in a study conducted on 85 
patients on HD (Sklar, Riesenberg, Silber, Ahmed, & Ali, 1996). In terms of ‘distress,’ fatigue has 
been described as the most bothersome symptom by individuals on HD (Almutary et al., 2013; 
Macdonald, Fearn, Jibani, & Marcora, 2012).  
Other than the physical, cognitive, and affective components, fatigue is reported to be 
severe, distressing and associated with reduced physical performance. A reduction in physical 
performance happens due to muscle fatigue. Various mechanisms such as oxidative stress 
(Modaresi, Nafar, & Sahraei, 2015; Scholze, Jankowski, Pedraza-Chaverri, & Evenepoel, 2016), 
mitochondrial dysfunction (Che, Yuan, Huang, & Zhang, 2014), or vascular changes in the 
capillaries that affect skeletal muscle function lead to fatigue (Adams, 2005). In 10 individuals on 
HD, peak oxygen consumption was reduced as measured by the cycle ergometer test indicating 
impaired exercise performance (Petersen et al., 2012). Another investigator reported low 6-minute 
walking distance across all age groups in 90 individuals on HD (Pajek et al., 2016). From these 
studies one can infer that in participants with HD, physical performance is reduced due to muscular 
fatigue and, perhaps, can be demonstrated through performance- based testing. 
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The literature available on epidemiology and factors associated with fatigue in CKD is 
surprisingly limited by a select population with focus on African-Americans, small sample size, 
inconsistencies in the correlates of fatigue, and flawed self-report fatigue measures (McCann & 
Boore, 2000; Williams, Crane, & Kring, 2007). These studies have been mostly conducted outside 
the US (Bossola, Luciani, & Tazza, 2009; Bossola et al., 2018, 2011, Bossola & Tazza, 2015, 
2016; Letchmi et al., 2011; McCann & Boore, 2000). Fatigue is associated with negative outcomes 
such as increased cardiovascular risk, morbidity and premature death (Jhamb et al., 2009; Jhamb, 
Weisbord, Steel, & Unruh, 2008; Koyama et al., 2010; Sakkas & Karatzaferi, 2012). Fatigue hasn’t 
been receiving much attention until recently, as it is considered an inherent part of the disease 
process and something that cannot be changed or is tenable to intervention (McCann & Boore, 
2000). Under-recognition of fatigue could be also due to the invisible, insidious nature of fatigue 
(Horigan, 2012). In individuals on HD, fatigue remains an undertreated and under-recognized 
symptom despite the high prevalence and associated critical outcomes (Artom et al., 2014; 
McCann & Boore, 2000). There is a need to focus on more evidence about this negative symptom. 
Fatigue Assessment in Individuals with HD 
Various tools that have been used to assess fatigue in individuals with HD include 
unidimensional and multidimensional tools. Some of the unidimensional tools that have been 
repeatedly utilized are VAS-fatigue, the Fatigue Severity Scale, and the Short Form-36 (SF-36) 
vitality scale (Artom et al., 2014; Horigan, 2012). These unidimensional tools provide a single 
score in the end that measure one single aspect of fatigue such as severity or vitality. Surprisingly, 
most of the studies focusing on fatigue in CKD have used unidimensional tools for assessment 
(Bonner, Wellard, & Caltabiano, 2010; Bossola, Luciani, Giungi, & Tazza, 2010; Bossola & 
Tazza, 2015; Jhamb et al., 2009; Karadag, Kilic, & Metin, 2013; Williams et al., 2007). The SF-
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36 vitality scale is a quality of life assessment tool that has been utilized in individuals on dialysis 
to assess their fatigue levels. For example, the large scale study ‘Impact of Outcomes on 
Hemodialysis (HEMO)’ study that was conducted in the US population used SF-36 to assess 
fatigue (Jhamb et al., 2009, 2011). However, SF-36 scale may not completely capture fatigue 
severity in the dialysis population (Jhamb et al., 2009). Also, SF-36 suffers from limitations such 
as the floor effect. Another frequently used measure of fatigue, VAS, is a single item measure that 
also suffers from floor and ceiling effects (Hawker, Mian, Kendzerska, & French, 2011). Floor 
effect happens when most of the reported scores lie on the lower level score of the instrument, 
whereas ceiling effect happens when most of the scores reported bunch together on the upper level 
score of the instrument. A psychometrically sound unidimensional tool will have a normal 
distribution of scores. 
Among the list of multidimensional tools for fatigue assessment in individuals with HD, 
the Multidimensional Fatigue Inventory-20, the Functional Assessment of Chronic Illness 
Therapy-Fatigue, & the Piper Fatigue Scale (PFS) are some of the most commonly used in previous 
studies (Artom et al., 2014; Horigan, 2012). Multidimensional tools give separate scores for 
various subscales, and therefore, cover various aspects of fatigue in one tool such as physical, 
mental, general, or affective fatigue (Whitehead, 2009). Fatigue being a multidimensional 
construct requires multidimensional tools. However, few investigators have used 
multidimensional tools for fatigue assessment in individuals on HD (Biniaz et al., 2013; Karakan, 
Sezer, & Ozdemir, 2011; Letchmi et al., 2011; Liu, 2006; McCann & Boore, 2000). Therefore, 
more studies are required that use multidimensional tools for fatigue assessment in the same 
population. 
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Various tools used in individuals on dialysis, either unidimensional or multidimensional 
have another limitation, in that individuals have to answer questions based on their experiences in 
the past weeks to months. There is a possibility for participants to suffer from recall bias. Further, 
individuals on dialysis suffer from day to day and within the day (day of dialysis) variations in 
fatigue that an instrument with long recall periods cannot capture (Abdel-Kader et al., 2014). 
Therefore, fatigue in CKD requires tools that assess self-reported fatigue momentarily. 
Performance-based tests may be a means of assessing fatigue in real time. A six- minute 
walk test gives a real time assessment of the individuals’ momentary fatigue levels by measuring 
the distance walked by the individual. Some investigators have reported the use of six- minute 
walk test to measure physical performance in individuals on dialysis (Dziubek et al., 2016; 
Manfredini et al., 2017; Pajek et al., 2016). More studies are needed utilizing objective measures 
along with “gold standard” self-report measures to measure fatigue in dialysis. 
Factors Influencing Fatigue in HD 
There is limited research on fatigue and its associated factors in HD in the US population. 
Past studies have been conducted in Taiwan, Iran, Malaysia, Turkey, Ireland, India, Australia and 
Italy (Horigan, 2012). Every culture and geographical region is different, and therefore, the 
severity, quality and duration of fatigue and associated factors might be different in the US 
population from the other geographical regions. Myriad factors influence fatigue in individuals on 
HD including physiological, psychological, and situational. 
Multiple physiological factors are known that cause fatigue in individuals on chronic HD 
treatment. One of the most common reasons for fatigue is sudden fluid shifts that happen during 
dialysis, causing ‘post-dialysis fatigue.’ Ultrafiltration, diffusion and osmosis are some of the 
processes that determine fluid shifts across the membrane (Horigan, 2012; Sklar et al., 1996). If 
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too much fluid is removed during dialysis or too much weight is gained after last dialysis treatment, 
fatigue can result. Another factor causing fatigue is anemia, which occurs due to insufficient 
production of erythropoietin by the kidneys in Stage G5 CKD (Zadrazil & Horak, 2015). Various 
other physiological factors that have been implicated in the pathogenesis of fatigue are uremia, 
protein energy malnutrition, levo-carnitine deficiency, chronic inflammation, dialysis inadequacy, 
presence of comorbidities such as hypertension, diabetes, cardiovascular disease, old age and sleep 
disorders (Jhamb et al., 2013; Joshwa & Campbell, 2017; Joshwa, Khakha, & Mahajan, 2012). 
However, equivocal relationships have been found between various physiological factors such as 
anemia and uremia with fatigue. More studies are required to explore the relationship of these 
variables with fatigue. 
Some of the psychological factors that predict fatigue in individuals on HD and have been 
studied widely are depression and anxiety. Depression is thought to cause fatigue through 
inflammatory cytokines such as interleukin-6 in individuals on HD (Bossola, Di Stasio, Giungi, 
Rosa, & Tazza, 2015). A moderate relationship has been found in multiple investigations between 
depression and fatigue, with few investigators not finding any relationship between the two 
variables (Artom et al., 2014). Other psychological factors that are associated with fatigue are 
anxiety, suicide risk, stress and social support (Karadag et al., 2013; Letchmi et al., 2011). 
Situational factors that are related to fatigue in individuals on HD include age, gender, race, 
educational status, and marital status. Among these factors, females (Liu, 2006), white race (Artom 
et al., 2014; Jhamb et al., 2009), unemployment status (Liu, 2006), and unmarried status have been 
found to be associated with increased fatigue in HD. Consistently, race has been associated with 
fatigue severity, but relationship with age, gender, marital status (Bayumi, 2015; McCann & 
Boore, 2000; O’Sullivan & McCarthy, 2007), educational status have been equivocal across 
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studies. More evidence is required to explore these relationships. Variability in the findings limits 
our ability to propose interventions for those who are at high risk of developing fatigue (Picariello, 
Moss-Morris, Macdougall, & Chilcot, 2017). 
Given that the existing evidence on fatigue in individuals on dialysis have been limited by 
flawed unidimensional tools, lack of objective measures for fatigue assessment, underpowered 
samples, variable findings in terms of the correlates of fatigue; this study aims to examine the 
severity and trajectory pattern of fatigue and delineate various physiological and situational factors 
that influence fatigue severity in individuals with CKD Stage G5 on HD in a powered, ethnically 
diverse sample using multidimensional patient reports and performance measures. Studying the 
severity and trajectory patterns of fatigue will help in identifying the dynamics of fatigue that these 
individuals on HD go through. Knowledge of factors that predict fatigue may lead to identifying 
individuals on dialysis that are at high risk for fatigue. Potential findings from this study may lead 
to appropriate interventions to alleviate fatigue levels in participants on HD.  
Significance of the Study 
Number of demises occurring in Stage G5 CKD on dialysis therapy is very high, with 
cardiovascular deaths contributing to more than half of the deaths (“Kidney Disease Statistics for 
the United States,” 2016). Fatigue has been linked with an increased risk of cardiovascular events, 
because there is a greater degree of underlying inflammation compared to healthy adults, which 
contributes to coronary artery disease and mortality (Aukrust et al., 2008). Premature death is 
known to occur in individuals with CKD having excessive fatigue and lower vitality scores (Jhamb 
et al., 2009). Besides these significant outcomes, fatigue also may have a negative effect on an 
individual’s daily performance, activities, professional life, relationship with family and friends, 
sex life and course of treatment (Bonner et al., 2010). An individual with fatigue becomes 
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physically inactive and becomes more dependent (Jhamb et al., 2011). The capacity to engage in 
daily activity and exercise is reduced (Bonner et al., 2010). There is a considerable reduction in 
mental, physical, social and functional capacities further affecting quality of life (Jhamb et al., 
2008).  
Given that fatigue is associated with various negative health outcomes, such as increased 
cardiovascular morbidity, mortality, increased dependence on others and reduced physical activity, 
depression, and anxiety; there is a need to focus our research efforts onto this understudied 
symptom. There is limited research conducted on fatigue in individuals with Stage G5 CKD on 
HD in US. 
This study aimed to examine the various dimensions of fatigue in the Michigan HD 
population and examine the various situational and physiological factors that are related to fatigue, 
and therefore would help in understanding the biological mechanisms that cause fatigue in 
individuals with Stage G5 CKD on HD. This aim is in alignment with one of the research priorities 
of the National Institute of Nursing Research (NINR) which proposes to understand the biologic 
basis behind symptoms like fatigue in various chronic illnesses. NINR proposed that a “better 
understanding of symptoms….will improve clinical management of illness and lead to more 
productive lives” (“Symptom Science | National Institute of Nursing Research,” n.d.). Existing 
literature on various factors associated with fatigue suggests equivocal results and therefore, this 
study aimed to confirm or refute the findings from previous studies through a rigorous, 
multidimensional assessment with a powered sample. Variability in the findings on factors 
associated with fatigue limits our ability to propose interventions for individuals with Stage G5 
CKD on HD. A predictive model of fatigue may be proposed from the results of this study data 
that will accurately identify individuals at risk for severe fatigue. Currently, there is no consistent 
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model to predict fatigue and management of fatigue relies primarily on treating anemia and 
increasing physical activity to alleviate fatigue (Picariello et al., 2017). Appropriate interventions 
directed towards high risk individuals with fatigue may help in improving quality of life and 
reducing morbid cardiovascular events in the CKD population. 
This study is in alignment with the mission of the American Nurses Association (“About 
ANA |American Nurses Association,” n.d.), in that it will contribute to improving the health of 
patients by achieving a greater quality of life in individuals with Stage G5 CKD on HD. This study 
utilized the Theory of Unpleasant Symptoms (TOUS) as the framework to generate various 
hypotheses based on the relevant past literature, and thereby, the results obtained from this study 
provided confirming evidence towards hypothesized relationships in the theory and eventually 
contributed towards the discipline of nursing.   
Purpose of the Study 
The purpose of this descriptive, correlational study was to examine the severity and 
trajectory pattern of fatigue and delineate various physiological and situational factors that 
influence fatigue severity in individuals with CKD Stage G5 on HD.  
Specific Aims 
Aim 1: Examine the severity and trajectory pattern of fatigue in individuals with Stage G5 
CKD on HD. 
Research Question 1a: How severe was the level of behavioral, cognitive and affective fatigue pre 
and post dialysis? 
Research Question 1b: How frequently did the HD participants describe being fatigued? 
Research Question 1c: Did the mean fatigue scores differ from U.S. and other chronic disease 
populations? 
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Research Question 1d: What was the trajectory of fatigue severity from the pre-dialysis to the post-
dialysis period? 
Research Question 1e: What was the impact of fatigue on the physical performance of HD 
participants pre and post dialysis? 
Aim 2: Identify the extent to which select physiological factors such as anemia, dialysis 
adequacy, inter-dialytic weight gain, co-morbidities, and age influence fatigue severity in 
individuals with Stage G5 CKD on HD. 
Hypothesis 2: There was no relationship between anemia, dialysis adequacy, co-morbidities, inter-
dialytic weight gain and age with fatigue severity. 
Aim 3: Identify the extent to which select situational factors such as living status, 
employment, gender, and race influence fatigue severity in individuals with Stage G5 CKD 
on HD. 
Hypothesis 3: There was no significant difference in fatigue severity with respect to gender, race, 
employment, and living status.
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CHAPTER 2: THEORETICAL FRAMEWORK AND SELECTION OF VARIABLES 
Theory of Unpleasant Symptoms (TOUS) 
The TOUS was used to guide the present study. According to Lenz & Pugh (2018), the 
TOUS was designed to improve understanding of a symptom in various contexts and provide 
information on designing new ways to prevent, ameliorate or manage unpleasant symptoms and 
their negative effects. The theory has three major concepts- the symptoms, influencing factors, and 
performance outcomes. The theory states that three interrelated categories of factors particularly, 
physiological, psychological, and situational factors influence a given symptom, the experience of 
that symptom and how an individual perceives a symptom. The ‘symptom experience’ affects the 
individual’s performance, which encompasses cognitive, physical, and social functioning (see 
Figure 1) (Lenz & Pugh, 2018).  
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Figure 1. Theory of unpleasant symptoms (Lenz and Pugh, 2018) 
Symptoms can be isolated or are clustered and are reported by the individual; sometimes 
objective signs are apparent. Symptoms are affected by various contextual factors (Lenz & Pugh, 
2018). The rationale behind selecting this middle-range theory is that it focuses on 
symptom/symptoms, highlights multidimensionality, and delineates various factors that influence 
a given symptom, which was in alignment with the purpose of this proposed study. Symptoms are 
subjective and can be measured only through self-report although objective signs may be visible. 
Therefore, this study focused on a combination of subjective reports and objective performance 
measures to study fatigue. Also, the TOUS suggests that symptom is an unpleasant concept, and 
since fatigue is an unpleasant and distressing symptom, the TOUS seemed to be a perfect fit for 
this proposed study.  
Propositions of Interest 
The propositions from TOUS that are linking the concepts of interest are the following: (1) A 
symptom has multiple measurable dimensions including quality, distress, severity and timing as it 
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occurs. (2) Physiological factors, situational factors, and psychological factors influence a 
symptom and its dimensions. 
Theoretical Constructs  
The two major constructs that are of interest from TOUS for this study are symptoms and 
influencing factors.  
Symptoms. According to Lenz & Pugh (2018), symptoms are defined as perceived 
indicators of change in normal functioning as experienced by individuals. Symptoms are 
conceptualized as having measurable dimensions such as quality, intensity/severity, distress and 
time as shown in Figure 1. ‘Quality’ is the nature of the symptom or the way it is manifested or 
experienced. ‘Intensity’ refers to the degree, strength, or severity of the symptom. ‘Distress’ is the 
degree to which the individual experiencing the symptom is bothered by it. The dimension of ‘time’ 
defines the frequency and duration of the symptom (Lenz & Pugh, 2018). The present study 
focused on fatigue as a symptom and measured various dimensions including intensity/severity 
and timing of fatigue experienced by the person. Severity of fatigue was the dependent variable in 
this study. The present study examined the level of sensory, cognitive and affective fatigue and 
has been added in Figure 2.   
The TOUS states that symptoms can have observable signs along with subjective feelings 
(Lenz & Pugh, 2018). Therefore, this study utilized an objective measure to assess fatigue 
indirectly through reduced physical performance.  
Influencing factors. Influencing factors are the factors that are relevant in producing a 
given symptom which includes physiological, situational and psychological factors.  
Physiological factors. These factors include anatomical, physiological, genetic and 
treatment-related variables. For instance, the presence of structural anomalies, existence of 
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pathology, stage or duration of illness, inflammation due to infection and age are examples. 
Relevant physiological factors that were measured in this study follow.  
Anemia. Anemia is caused due to reduced production of erythropoietin by the kidneys in 
CKD, and fatigue is a manifestation of anemia especially in HD. Anemia in CKD is diagnosed by 
serum hemoglobin values falling below 13 grams per deciliter (g/dL) in males and below 12 g/dL 
in females(“Anemia in CKD | KDIGO,” 2012). Various investigators have looked at the 
relationship between anemia and fatigue. In a longitudinal study conducted on 28 individuals in 
Australia suffering from Stages 3-5 CKD, low serum hemoglobin was moderately correlated with 
fatigue (r = .39, p < .05) (Bonner et al., 2013), with similar findings reported by a few investigators 
(Jhamb et al., 2013; Karakan et al., 2011; Williams et al., 2007). Contradictory findings have been 
reported by a majority of the investigators, in that they did not report a significant association 
between anemia and fatigue in individuals with CKD on HD (Bossola, Di Stasio, Antocicco, & 
Tazza, 2013; Bossola et al., 2009; Jhamb et al., 2009; Letchmi et al., 2011; Liu, 2006; McCann & 
Boore, 2000). These equivocal findings may be due to erythropoietin therapy and having 
homogenous levels of hemoglobin. Further exploration into the relationship between anemia and 
fatigue severity was done.  
Co-morbidities. Co-morbidities refers to the disorders that an individual is suffering from 
at a time. A study conducted in individuals on hemodialysis reported that individuals with worse 
fatigue were more likely to have severe comorbidities (Jhamb et al., 2009). Another study reported 
a similar finding, with significantly positive correlations between post-dialysis fatigue and 
comorbidities (r = .14, p = .031) (Han & Kim, 2015). The present study explored relationship 
between pre-dialysis fatigue and post-dialysis fatigue with comorbidity scores. 
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Inter-dialytic weight gain (IDWG). IDWG is the difference in the weight between two 
consecutive dialysis sessions due to fluid and salt accumulation. The weight gained is calculated 
from pre-dialysis weight minus the post-dialysis weight of the previous HD session. Normally, a 
70 kg individual should gain 2.4 kg between dialysis sessions (Daugirdas et al., 2015). A weak 
correlation of fatigue with IDWG (r = .25, p < .05) was reported in a group of 104 individuals on 
HD in Korea (Kim & Son, 2005). Higher IDWG are associated with higher fluid removals during 
a HD session and thereby higher ultrafiltration rate which might be contributing to greater fatigue 
levels. Exploration about the relationship between IDWG and fatigue severity was done. 
Age. A weak, positive insignificant correlation was found between fatigue and age in an Irish 
study in 46 individuals on HD (r = .20, p = .09) (O’Sullivan & McCarthy, 2007). Older participants 
with CKD have significantly higher levels of fatigue than younger participants (Liu, 2006). 
Consistent findings have been reported on older participants tending to be more fatigued in 
participants on HD (Bossola et al., 2009; Kim & Son, 2005; Letchmi et al., 2011). One possible 
explanation is that older participants have more co-morbidities compared to younger participants, 
contributing to higher fatigue levels. Further exploration of age and fatigue severity was done in 
this study. 
Dialysis adequacy. Dialysis adequacy is measured by various methods and calculation of Kt/V 
is one of them (“Hemodialysis Dose & Adequacy | NIDDK,” 2014). A value of 1.2 or higher 
indicates adequate dialysis. Many investigators have not found an association between fatigue and 
inadequate dialysis (Bossola et al., 2018; Liu, 2006; Mollaoglu, 2009). An investigator in Iran 
found significant association (p = .01) between fatigue and dialysis adequacy in 43 patients on HD 
(Dadgari, Dadvar, & Eslam-Panah, 2015). Inadequate dialysis causes a higher circulation of 
uremic solutes in the blood and may cause fatigue in patients on HD. Investigators have found 
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association between uremia and fatigue levels in the past (Wang et al., 2016). Uremia might be 
acting as a mediator of the relationship between dialysis inadequacy and fatigue. Further 
exploration of relationship between dialysis adequacy and fatigue was done in this study. 
Situational factors. According to TOUS, situational factors encompasses individual’s 
social and physical environment. Examples are socio economic status, living status, temperature, 
light, pollution, and others (Lenz & Pugh, 2018). The situational factors in the present study 
included living status, employment status, race and gender; a review of which is provided below. 
Living status. Living status means if the individual resides with anyone such as spouse, 
parents, relatives, or no-one. No significant difference between fatigue and being married versus 
not married (F (3, 41) = .50, p = .68) was found (O’Sullivan & McCarthy, 2007). Similar findings 
were reported by McCann & Boore (2000) and Bayumi (2015). The reason behind married 
individuals having lower fatigue levels could be due to the moral and psychological support 
provided by the spouse (Liu, 2006), however, none of the previous studies have found any 
relationship between marital status and fatigue. By convention, marital status has been studied 
frequently. The present study explored the relationship between fatigue severity and living status 
as living status may be a more relevant construct than marital status. 
Employment. Unemployed individuals were more fatigued than their employed 
counterparts in Taiwan individuals on HD (Lee et al., 2007). Usually staying at home when 
unemployed might decrease physical activity and social support from colleagues, thereby 
increasing fatigue levels. Contrasting findings were reported by other investigators (McCann & 
Boore, 2000; O’Sullivan & McCarthy, 2007). The present study explored more about relationship 
between employment status and fatigue severity.  
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Gender. The majority of investigators have reported females being more fatigued than 
males, which could be due to females articulating their feelings more than males (O’Sullivan & 
McCarthy, 2007). Females were more fatigued than males in Taiwanese individuals on HD (Liu, 
2006). Similar findings have been reported by other investigators (Kim & Son, 2005). 
Contradictory findings were reported by Bayumi (2015), in that men were more fatigued compared 
to women in participants receiving HD therapy. No significant difference in fatigue scores was 
observed between males and females in an Irish study on 39 individuals on HD (McCann & Boore, 
2000). Further exploration was done on the relationship between gender and fatigue severity in 
this study. 
Race. Among 36 African-American females on HD, 75% were reported to be fatigued 
(Williams et al., 2007). However, another investigator reported fatigue to be less prevalent in 
African-Americans and Asians compared to non-African-Americans (Artom et al., 2014). 
Similarly, African-American individuals on dialysis reported more energy than non-African-
Americans (Jhamb et al., 2009). Caucasians take longer to recover from fatigue after dialysis 
sessions than African-Americans (Cardenas & Kutner, 1982). In fact, African Americans reported 
better psychological well-being and lower burden of disease in another study (Unruh et al., 2004). 
With CKD being more prevalent in African-Americans (“Kidney Disease Statistics for the United 
States,” 2016), one would postulate that fatigue will be more prevalent in African-Americans. The 
paradoxical findings might be due to greater spiritual well-being in African-Americans (Tanyi & 
Werner, 2007). The present study explored relationship between fatigue severity and race. 
Amongst the influencing factors proposed for this study, consistent relationships have been 
observed between race, age and fatigue severity. Other influencing factors in CKD that have shown 
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equivocal relationships with fatigue include anemia, living status, gender, and employment status. 
Variables such as IDWG have been examined only by a few studies and was explored in this study. 
Theoretical Model 
The conceptual model shown in Figure 2 summarizes TOUS and hypothesized 
relationships that are relevant to the present research study. The middle range theory concepts are 
shown along with the variables from literature review in fatigued individuals with CKD. Figure 3 
illustrates the application of TOUS to the select variables chosen for this study. In addition, 
measures for the select variables are identified and are described in the next chapter. 
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Figure 2. Conceptual theoretical model based on Theory of Unpleasant Symptoms 
 
Figure 3. Substruction model showing relevant concepts, variables and empirical indicators
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CHAPTER 3: METHODOLOGY 
Purpose of the Study 
The purpose of this descriptive, correlational study was to examine the severity and 
trajectory pattern of fatigue and delineate select physiological and situational factors that 
influenced fatigue severity in individuals with CKD Stage G5 on HD.  
Specific Aims and Hypothesis 
Aim 1: Examine severity and trajectory pattern of fatigue in individuals with Stage G5 CKD 
on HD. 
Research Question 1a: How severe was the level of behavioral, cognitive and affective fatigue pre 
and post dialysis? 
Research Question 1b: How frequently the HD participants described being fatigued? 
Research Question 1c: Did the mean fatigue scores differ from U.S. and other chronic disease 
populations? 
Research Question 1d: What was the trajectory of fatigue severity from the pre-dialysis to the post-
dialysis period? 
Research Question 1e: What was the impact of fatigue on the physical performance of HD 
participants pre and post dialysis? 
Aim 2: Identify the extent to which select physiological factors such as anemia, dialysis 
adequacy, inter-dialytic weight gain, comorbidities, and age influence fatigue severity in 
individuals with Stage G5 CKD on HD. 
Hypothesis 2: There was no relationship between anemia, inter-dialytic weight gain, dialysis 
adequacy, co-morbidities, and age with fatigue severity. 
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Aim 3: Identify the extent to which select situational factors such as living status, 
employment, gender, and race influence fatigue severity in individuals with Stage G5 CKD 
on HD. 
Hypothesis 3: There was no significant difference in fatigue severity with respect to gender, and 
employment, race and living status. 
Design 
A quantitative, non-experimental, descriptive, correlational, before-after design was 
utilized in this study. A before-after design was considered because of the significant diurnal 
changes in fatigue severity levels and some of the associated factors, before and after dialysis. A 
pictorial representation of the research design is shown in Figure 4. The primary outcome measures 
were fatigue severity, whereas, the independent variables were anemia, IDWG, dialysis adequacy, 
age, comorbidities, living status, gender, employment status, and race.  
 
Figure 4. Non-experimental, before-after design 
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Sample 
A non-probability, convenience sampling method was employed, since the study included 
only those patients who were visiting collaborating clinics, a description of which is provided in 
section ‘Setting.’ Individuals were screened according to the following inclusion/exclusion 
criteria. 
Inclusion/ Exclusion Criteria 
The inclusion criteria involved the following: (1) Participants who provided consent to 
participate and were between 18-89 years. (2) Participants who could understand/ converse in 
English language. (3) Participants with established diagnosis of CKD Stage G5 greater than 3 
months and were on HD twice or thrice per week. (4) Participants who were conscious and alert 
enough to answer the questions according to Mini Cognitive assessment score (Appendix-A).  
The exclusion criteria for 6-minute walk test included: (1) Participants who had mobility 
restrictions and relied on wheelchair for transportation purposes. (2) Participants who were unable 
to walk. (3) Participants who did not give a verbal approval or were not confident to walk. (4) 
Visual gait checks on the patient prior to walk showed instability to walk. (5) Participants with 
conditions such as unstable angina during the previous month, recent myocardial infarction in the 
previous month, resting heart rate of more than 120 per minute, & hypotension (Blood pressure< 
90/50 mmHg) at time of 6MWT. (6) Patient reported about hypotensive signs like light 
headedness, nausea, vomiting and cramps. (7) Any episodes of intradialytic hypertension 
associated with an increase in systolic blood pressure >90 mmHg from pre-dialysis to post dialysis. 
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Setting 
The target population was individuals diagnosed with CKD Stage G5 and were on HD 
twice or thrice a week. Our accessible population were individuals who were visiting the selective 
outpatient DaVita dialysis clinics in South East Michigan. Individuals who visited these dialysis 
clinics were primarily from Metro Detroit and Southeast Michigan. DaVita Health Care is a non-
profit organization that has a chain of approximately 1500 dialysis clinics across the United States. 
The initial point of contact was the feasibility coordinator, who handled activities at the DaVita 
Clinical Research Center. This research center has a Protocol Review Committee that monitors 
research activities at DaVita across the U.S. After the Protocol Review Committee approved the 
study protocol, the PI reached out to the 3 DaVita dialysis clinics that participated in the study. 
Selection of these 3 clinics was based on feasibility and ethnic mix of population and a summary 
of the clinics is provided in Table 2. Permissions were obtained from the specific Regional 
Operational Director, Facility Administrator and Medical Directors of these clinics through emails 
and in-person meetings before beginning the project. 
Table 2 
 Summary of Participating Sites 
Facility  Location  Distance from WSU* 
campus(miles) 
Dialysis patients 
enrolled in clinic 
DaVita Health Care Clinton Township 26 60 
DaVita Health Care Macomb 14.5 90 
DaVita Health Care Partridge Creek 28.1 40 
*WSU: Wayne State University 
Sample Size 
The actual power depends on the specific statistical test used for a given sample size and 
estimated effect size. The apriori power analyses were run and findings are as follows. For research 
questions 1d & 1e, using paired samples test, a sample of 34 participants was required. This sample 
26 
 
 
size is based on a formulation of 80% power, a medium effect size of 0.5, and a significance of 
0.05. For Hypothesis 2, using Pearson Correlation, 64 participants were required. This sample size 
is based on a formulation of 80% power, a medium effect size of 0.3, and a significance of 0.05. 
For Hypothesis 3, using Chi-square test, a sample of 110 participants was required. This sample 
size is based on a formulation of 80% power, a medium effect size of 0.3, and a significance of 
0.05. To address all the hypotheses in this study, approximately 110 participants were required. 
Sample size calculations were performed using the G power 3 (Faul, Erdfelder, Buchner, & Lang, 
2009). Based on the declination rates, we expected a 40% attrition rate and the total targeted sample 
size was increased to 150 participants. 
Post-hoc power analyses were done to see if there was enough power in the study. For Chi-
square, this study achieved 89% power with a moderate effect size with 86 participants. For 
multiple regression, with five predictors there was 77% power. For logistic regression, a power of 
42% was achieved with an odds ratio of 1.5. For running t-tests, there was a power of 99% with 
moderate effect size. For independent t-tests, there was 95% power based on 86 participants in the 
study. 
Recruitment Procedures and Screening 
Permission from the Institutional Review Board of Wayne State University (Appendix-C) 
was obtained for ethical clearance in February 2018. A letter of support (Appendix-C) was 
obtained from DaVita Clinic Research Center and after the Protocol Review Committee approved 
the study in April 2018, the project began at the specific dialysis clinics in May 2018. The principal 
investigator (PI) reached out to the specific dialysis clinic Facility Administrators/Medical 
Directors and explained what was needed from the clinic staff. Data were collected from May 2018 
to December 2018.  
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The staff were involved in screening the participants and completed Health Insurance 
Portability and Accountability Act of 1996 (HIPAA) form (Appendix-B) with the participants who 
were interested in the study. A waiver from IRB was requested to screen participants for eligibility 
before taking informed consent. Based on the inclusion criteria, participants were screened 
(Appendix-A) to look for eligibility by the dialysis clinic staff. If the patient was eligible, the 
dialysis clinic staff completed HIPAA form with the participants. The PI obtained informed 
consent (Appendix-B) from the participants who completed HIPAA from those who were 
interested in participating in Visit 1. A detailed description of the study was provided to the 
participant during the consent process. A mutually agreeable day of future dialysis was decided 
for interviewing the patient. Participants received 10-dollar gift cards after Visit 1 as a token of 
appreciation. Gift cards were from Walmart/Target/Meijer store. 
On the day of interview (Visit 2), before dialysis was initiated, interview was conducted 
for 15 minutes to measure fatigue levels using self-report measures, demographic information 
(age, living status, employment status, gender and race) and information about comorbidities 
(Appendix-A). After the interview, participants were screened for the 6MWT (Appendix-A). Vital 
signs (Heart Rate, Blood Pressure) were measured by the PI. If the participant was eligible for 
6MWT based on vital signs and walking history, the 6MWT was conducted. The 6MWT session 
took 15 minutes. Participants ineligible for 6MWT returned to the dialysis clinic for their dialysis 
session. Participants received 20-dollar gift cards after completing the pre-dialysis session. 
On the same day of interview (Visit 2) after the dialysis session, there was a post-dialysis 
interview session. The post dialysis interview session included measurement of fatigue levels using 
self-report measures. Vital signs were measured by the PI to determine eligibility for the 6MWT. 
The 6MWT was repeated after the post-dialysis interview based on the same screening criteria 
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used pre-dialysis. Participants received 20-dollar gift cards after completing the post-dialysis 
session. 
Weight was measured pre and post dialysis using the weighing scale installed in the 
specific dialysis clinics. Other necessary data (serum hemoglobin, recent dialysis adequacy and 
IDWG) were extracted from the medical records of the patient.  
Various strategies were employed to advertise about the research study and encourage 
participation. DaVita specific flyers (Appendix-B) were distributed to the staff/nurses of specific 
dialysis clinics. Nurses and dialysis staff helped in spreading information about the study through 
word of mouth. 
A few amendments were made in the study protocol and approved by the IRB in June, 
August 2018, and February 2019 regarding change in exclusion criteria, increase of enrollment 
number, deletion of key personnel, addition of key personnel and funding source. A continuation 
form was submitted to IRB in January 2019 to continue the study in case medical records need to 
be referred in the post enrollment and analyses period. The continuation was accepted by IRB in 
February 2019. 
Instruments 
This study included the following outcome measures derived from the TOUS.  
Fatigue and Multiple Dimensions 
This study measured quality, severity and timing of fatigue. The Piper Fatigue Scale-12 
(PFS-12) (Appendix-A) was used to measure fatigue severity and quality. The Patient Reported 
Outcomes Measurement Information System-Computer Adaptive Test (PROMIS CAT) for 
Fatigue (Appendix-A) measured fatigue severity and timing of fatigue. The 6-minute walk test 
(6MWT) (Appendix-A) was used to measure quality of fatigue, specifically motor fatigue. 
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Piper fatigue scale. A description of Piper Fatigue Scale follows. 
History. The Piper Fatigue Scale (PFS) was originally developed by Dr. Barbara Piper in 
1989 to measure multidimensional aspects of fatigue in individuals suffering from cancer. PFS is 
a self-reported, multidimensional measurement scale that measures subjective perception of 
current levels of fatigue. The original version of PFS contained 40 items (Piper et al., 1998, 1989). 
However, due to various limitations observed in PFS such as comprehension difficulty with the 
response scale, lengthy questionnaire, respondent burden and being impractical for quick 
assessments (Reeve et al., 2012), the shorter versions of Piper Fatigue Scale has been released. 
The 12-item version, PFS-12 was used in this study.  
Dimensions. The PFS-12 scale is composed of 12 numerically scaled items that measure 
four dimensions of fatigue using a simple rating from 0 to10 for each item. The four subjective 
dimensions are behavioral/severity, affective meaning, sensory, and cognitive/mood. The 
behavioral/severity dimension (three items) reflects the severity, distress of fatigue and changes in 
activities of daily living that could result from fatigue. The affective meaning dimension (three 
items) focuses on emotional meaning attributed to fatigue. The sensory dimension (three items) 
includes sensory symptoms of fatigue perceived physically such as feeling weak and tired. The 
cognitive/mood dimension (items items) includes perceptions of cognitive ability like difficulty 
with concentration/remembering ability (Clark, Ashford, Burt, Aycock, & Kimble, 2006).  
Scoring. In order to calculate the subscale/dimension scores, the scores of all items within 
the particular subscale are added, and this sum is then divided by the number of items within the 
particular subscale. This calculation provides us with a mean subscale score for the participant 
from 0 to 10. Similarly, a total fatigue score can be obtained by adding the 4 subscale scores and 
dividing this sum by 4. A total score of 0 means ‘no’ fatigue, 1 to 3 means ‘mild’ fatigue, 4 to 6 
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means ‘moderate’ fatigue, and 7 to 10 means ‘severe’ fatigue. These cut off scores have been 
validated in a group of breast cancer survivors (Stover et al., 2013). Higher scores on the subscale 
and the total fatigue scale reflect severe fatigue. 
Psychometrics. Excellent internal consistency of PFS-12 has been reported in a study with 
799 women survivors from breast cancer. PFS-12 had a Cronbach’s alpha of .92, along with the 
reliability for the PFS-12 subscales .89 (behavioral), .87 (cognitive/mood), .87 (affective), and .87 
(sensory) (Reeve et al., 2012). Another investigator found a similar Cronbach’s alpha reliability 
for the PFS-12 scale of .92 in 857 women survivors from breast cancer. Weak convergent validity 
was found between the PFS-12 and SF-36 physical function subscale (r = − .374, p < . 01), and 
moderate validity with the SF-36 mental function subscale (r = −.59, p < . 01) (Stover et al., 2013). 
A previous study that utilized PFS with 22 items in dialysis population did not report the validity 
in their findings (Karakan et al., 2011).  
The Cronbach’s alpha for the total scale in the current study was excellent, was .91 before 
dialysis and .94 after dialysis. For behavioral subscale alpha was .86 before dialysis, .92 after 
dialysis; affective subscale was .89 before dialysis, .93 after dialysis; sensory was .89 before 
dialysis, .91 after dialysis.; cognitive was .82 before dialysis and .79 after dialysis. 
Rationale for using PFS-12. The PFS-12 is a multidimensional tool and measured 
specifically four aspects of fatigue that are reported in individuals on HD. Physical, cognitive and 
affective fatigue were reported in Taiwanese individuals on HD using a phenomenological 
approach (Lee et al., 2007). The behavioral/severity and sensory subscale of PFS-12 may be 
related to the physical aspects of fatigue in HD and cognitive and affective subscale of PFS-12 
might be related to the psychological aspects of fatigue in individuals on HD.  
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Other multidimensional tools like the Multidimensional Fatigue Inventory-20 have been 
accused of not having an appropriate factor structure (Chilcot et al., 2017), and difficulty in 
comprehending the instrument (Artom et al., 2014). The Functional Assessment of Chronic Illness 
Therapy-fatigue is another tool that does not cover various aspects of fatigue such as behavioral, 
sensory, affective and cognitive domains (E. Smith, Lai, & Cella, 2010). Unidimensional tools like 
VAS, Fatigue Severity Scale only measure one aspect of fatigue and therefore, not appropriate for 
use in dialysis fatigue that has multiple dimensions (Whitehead, 2009). The revised and shorter 
version of PFS is preferred over the original version of PFS in the present study as it has 12 items 
compared to the 40 items in the original version, and therefore, there will be reduced respondent 
burden. Validity and reliability of PFS-12 has been shown to be acceptable in the past few studies 
(Reeve et al., 2012; Stover et al., 2013). To our knowledge, PFS-12 has not been utilized in the 
dialysis population before. Other versions of PFS, that has 22 items have been utilized in dialysis 
population (Karakan et al., 2011). The instrument is available free of cost and does not require any 
special training to administer.  
The recall period of PFS-12 is of current or 24 hours which is better than a 1 week recall 
period of other tools like Functional Assessment of Chronic Illness Therapy fatigue, and 
Multidimensional Fatigue Inventory-20. Greater chances of error can happen in a 1 week recall 
method. The peak-end cognitive heuristic rule states that the most intense (peak) and final (end) 
moments of an experience has an influence on the judgements made by a person retrospectively. 
This influence can bias self-reports of somatic symptoms. Surprisingly, an investigator reported 
that peak and end experiences do not have a significant effect on daily recall of fatigue in 
individuals with rheumatic disorders (Schneider, Stone, Schwartz, & Broderick, 2011). In patients 
with osteoarthritis related low back pain, it was found that recalled overall daily pain is highly 
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concordant with the average of several momentary pain measurements carried out on the same day 
(Perrot et al., 2011). Therefore, it can be postulated that a 24-hour recall is concordant with a 
person’s momentary symptom experience. The present study utilized PFS-12 which is a current or 
24-hour recall tool that is postulated to adequately measure the momentary, daily variations of 
fatigue in the dialysis population. 
PROMIS measures. The PROMIS measures were developed by National Institutes of 
Health (NIH) to assess a variety of outcomes and symptoms such as pain, fatigue, physical 
function, depression, anxiety and social function. PROMIS measures are standardized and 
rigorously tested in various populations (“PROMIS,” n.d.).  
PROMIS-fatigue. PROMIS fatigue measures mild to extreme sensations of tiredness and 
its impact on various aspects of life, including physical, social and mental activities. The 
instrument covers especially the experience of fatigue in terms of its intensity, duration and 
frequency in the past 7 days (“Patient-Reported Outcomes Measurement Systems- Fatigue,” 2015). 
This proposed study utilized PROMIS CAT fatigue for measuring fatigue pre-dialysis. 
PROMIS fatigue can be administered in short form and computer adaptive testing format 
to adults, children and parent proxies. Short forms are much shorter versions of this instrument, 
while the CAT format provides questions to the individual based on responses given. There are a 
total of 95 questions in the item bank, from which questions are retrieved.  
In PROMIS CAT, the computer provides questions with medium trait level initially. The 
next item is administered according to the individual’s previous response. The total time to 
administer the test is 3 to 5 minutes. The scores obtained from the individual responses are summed 
into a total also known as the ‘raw score,’ which is then converted to a T-score by the computer. 
In order to receive a fatigue score, an individual must respond to four to 12 items. The number of 
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items provided is response dependent and varies with every individual. The responses of the 
questions have five options ranging from ‘not at all’ to ‘very much.’ Questions that measure 
frequency have response options ranging from ‘never’ to ‘always.’ More questions administered 
to the individual decreases the chances of error in the scores obtained. A total score of 50 with a 
standard deviation of 10 is considered an average score. For fatigue, a score of 60 is 1 SD worse 
than average, and a score of 40 is 1 SD better than average. Therefore, higher scores obtained 
indicate more severe fatigue. The instrument is available free of cost from the Assessment Center 
on the National Institute of Health website, however, requires registration from the user (“Patient-
Reported Outcomes Measurement Systems- Fatigue,” 2015). 
Psychometrics. Test-retest reliability was established in two studies. PROMIS CAT fatigue 
was administered to 100 individuals with osteoarthritis and 100 from the general population, with 
the retest administered after 7 days, in that desirable test-retest reliability coefficients were 
obtained ranging from .80 to .92 (Broderick, Schneider, Junghaenel, Schwartz, & Stone, 2013). 
Similarly, another study conducted on 177 individuals with rheumatoid arthritis found desirable 
test-retest reliability estimates of .88 with the retest being administered after 2 days (Bartlett et al., 
2015).  
Repeatedly, good to excellent internal consistency has been reported. Internal consistency 
of PROMIS CAT fatigue was found to be .98 in individuals with rheumatoid arthritis (Bartlett et 
al., 2015). The internal consistency of PROMIS CAT fatigue is excellent when scale score ranges 
from 30 to 90 (“Patient-Reported Outcomes Measurement Systems- Fatigue,” 2015). Good 
internal consistency of .83 for PROMIS fatigue short form was reported in 60 individuals with 
sickle cell disease (Ameringer, Elswick Jr, & Smith, 2014). There are no studies that have utilized 
PROMIS-fatigue in HD population to our knowledge. A systematic review done by Ju et al (2018) 
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confirmed the same (Ju, Unruh, et al., 2018). In the current study, the Cronbach’s alpha was 
excellent (α =.96) based on five items administered to the individual.  
Concurrent validity of PROMIS CAT fatigue was found in correlating PROMIS CAT 
fatigue with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) (r = .76) with 
no p-value reported (Khanna et al., 2012). Correlation of PROMIS CAT fatigue with VAS-fatigue 
was .86 (p < .01) (Bartlett et al., 2015), with Fatigue Impact Scale was .86 in 133 individuals with 
multiple sclerosis (Senders, Hanes, Bourdette, Whitham, & Shinto, 2014). 
All domains of PROMIS measures including fatigue were administered to 100 individuals 
with osteoarthritis and 100 from the general population, where mean scores on each domain in 
osteoarthritis sample exceeded those from the general population (p < .001) thus, establishing 
known group validity (Broderick et al., 2013). 
Moderate discriminant validity of PROMIS CAT fatigue has been reported, in that the 
correlation of fatigue with differing constructs such as sleep, anxiety and depression being 
moderate to low. For example, correlation between PROMIS CAT fatigue and Center for 
Epidemiological Studies-Depression (depression scale) was .59, and with the Sleep Index scale 
was .49 in 143 individuals with scleroderma (Khanna et al., 2012). Similarly, moderate correlation 
of PROMIS CAT fatigue was reported with other differing constructs in PROMIS subscales, in 
that correlation with sleep subscale was .45, with depression subscale was .49 (Bartlett et al., 2015). 
Mild correlation of PROMIS fatigue with State Trait Anxiety Scale of .47 was found (Senders et 
al., 2014). All these correlations are in the moderate range from .30 to .50, suggesting that the 
discriminant validity is moderate. 
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Good convergence validity has been reported for PROMIS CAT fatigue, where it was 
significantly correlated with PROMIS fatigue short form (r = .88, p < .001) in 100 stable and 85 
individuals with chronic obstructive pulmonary disease (Irwin et al., 2015).  
PROMIS measures also uses a score metric where each individual question is linked to a 
presumed concept of fatigue, thereby increasing the validity of the instrument. The flexibility of 
PROMIS CAT to choose more informative questions offers more precision compared to a short 
form (Lai et al., 2011). 
The PROMIS fatigue item bank was evaluated across various chronic conditions, in that 
significant improvement in fatigue was observed at follow-up (Cella et al., 2016). Adequate 
responsiveness was reported for PROMIS fatigue in 229 child parent dyads (Howell et al., 2016). 
Advantage and rationale behind using PROMIS CAT fatigue. In this study PROMIS 
CAT fatigue is superior to various unidimensional tools like Fatigue Severity Scale, Visual Analog 
Scale-fatigue, Short Form-36 vitality subscale, Functional Assessment of Chronic Illness Therapy- 
fatigue as they measure one single aspect of fatigue. PROMIS CAT fatigue provides the option of 
studying various dimensions such as severity, duration and frequency of fatigue in one single tool.  
PROMIS measures are reliable and valid instruments, however, due to its novelty have not been 
used previously in the dialysis population. This study will be the first of its kind to use PROMIS-
CAT for fatigue in the dialysis population. Tools such as the Functional Assessment of Chronic 
Illness Therapy- fatigue used in large scale studies with the dialysis individuals suffer from floor 
and ceiling effects (Acaster et al., 2015), whereas PROMIS measures have been demonstrated to 
have fewer floor and ceiling effects (Khanna et al., 2012). 
The PROMIS CAT fatigue was preferred over PROMIS fatigue short forms as CAT is 
more precise than the PROMIS short form and therefore provides the option of having small 
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sample size in the study. The items in PROMIS CAT fatigue are adjusted according to the 
responses and therefore, is a personalized instrument for every participant. Also, the tool is 
available at no cost and once administered instantly provides the final scores after calibrating with 
the population norms (“Patient-Reported Outcomes Measurement Systems- Fatigue,” 2015). 
Six-minute walk test (6MWT). 6MWT measured motor fatigue in this study and informed 
‘quality’ dimension of fatigue according to TOUS. 
Rationale for selecting 6MWT. Due to various advantages of objective measures in general 
over self-report measures in terms of not having a recall bias and being more accurate (Polit & 
Beck, 2012), this study utilized an objective measure of fatigue. Various objective tools are 
available that measure fatigue, and one of the most direct way is through electromyography (EMG) 
that involves measuring electrical activity in a single muscle through insertion of needle electrodes 
into the skin. The cost of EMG equipment and the burden of using invasive electrodes in sick 
patients limits the use of EMG in the dialysis population. 
Various factors affect skeletal muscles in dialysis individuals, causing muscle fatigue also 
known as motor fatigue, eventually that leads to reduced functional or exercise performance 
(Adams & Vaziri, 2006). Therefore, indirectly fatigue is visible in the task a person performs and 
can be measured through performance-based tests.  
Various exercise-based tests have been related to muscle fatigue like treadmill/ bicycle 
ergometer testing. However, these tests are not considered safe in individuals with low exercise 
capacity. One of the golden standard method of measuring functional/exercise capacity is the 
cardiopulmonary exercise testing that also requires a treadmill. Various timed walking tests are 
also available such as 1-minute, 2-minute and 4-minute walk test which are shorter in duration, 
however, are considered not sensitive enough to measure functional capacity in an individual. A 
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longer duration walking test like a 12-minute walk test has been found to be too exhausting in 
individuals with respiratory and cardiac problems (Du, Newton, Salamonson, Carrieri-Kohlman, 
& Davidson, 2009; Venkatesh et al., 2011). 
Measurement of functional performance is possible through a 6-minute walk test (6MWT). 
This study used 6MWT in HD individuals as superior to all the available objective measures to 
assess muscle fatigue. A 6MWT is considered safe and does not require much exertion like other 
exercise-based tests. A 6MWT is performed at a submaximal level of exertion, which is similar to 
the level of exertion at which one performs various activities of daily living (Pajek et al., 2016; 
Venkatesh et al., 2011). A 6MWT is more feasible, available at no cost and requires no special 
equipment such as EMG. Results obtained from a 6MWT are easy to interpret and does not require 
much training as needed for EMG wave interpretation. Also, a 6MWT has been found to be 
correlated with EMG manifestations of fatigue as measured by conduction velocity from vastus 
medialis and vastus lateralis muscle during an isometric knee extension in participants with chronic 
obstructive pulmonary disease (Boccia et al., 2015). In another study in multiple sclerosis 
participants, strong correlation was observed with short-form 36 physical function subscale 
(Goldman, Marrie, & Cohen, 2008). A detailed description of 6MWT follows. 
According to the American Thoracic Society (2002), a 6MWT measures exercise tolerance 
also known as functional capacity in various chronic disorders and was developed by Balke in 
1963. This test measures the distance an individual walks over 6 minutes on a flat surface. The 
participant is allowed to pace his walk and asked to walk as far as possible in 6 minutes in a marked 
hallway. This test has been applied in pediatric, adult healthy populations and across various 
diseases such as osteoarthritis, fibromyalgia, heart failure, chronic obstructive pulmonary disease 
and stroke (“ATS Statement,” 2002). 
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Method and contraindications. The test was performed in a hallway of length ranging 
from 50 feet to 71 feet with cones placed at the beginning and end of the hallway. Ideally, the 
course must be 30 meters in length, however, an investigator found no significant effect of length 
course on the distance walked (Sciurba et al., 2003). Before the walk test was started, the 
participant sat on a chair for 6-8 minutes and his/her pulse and blood pressure were measured to 
see if it they were in normal limits. The participant was instructed to walk as quickly as possible, 
with breaks if participant needed them. Comfortable shoes, clothes, and walking aids can be used 
by the patient. Constant encouragement was provided frequently throughout the 6 minutes. 
Training was required for the researcher who administered the test. A total of 15 minutes was 
required to administer the test. The researcher performing the test is required to have Basic Life 
Support and Advanced Life Support Certification in case of any adverse event during the test 
(Enright, 2003).  
Conditions such as unstable angina/recent myocardial infarction during the previous 
month, hypertension (>180/100 mmHg), and tachycardia of resting heart rate greater than 120 are 
considered contraindications as they are associated with a higher risk of cardiac arrhythmias during 
the 6MWT. The present study did not use hypertension as an exclusion criterion for participants 
as these individuals on dialysis are usually hypertensive on a daily basis and excluding them would 
result in losing a major cross-section of the dialysis population. This decision was taken under the 
discretion of the dialysis nephrologist, Medical Director, DaVita Clinton Township, Michigan. 
The 6MWT test should be stopped in case of any chest pain, shortness of breath, leg cramps, 
staggering, diaphoresis and pale appearance (“ATS Statement,” 2002). 
  Scoring. The distance covered in meters or feet was measured over 6-minutes, with lower 
scores on the distance covered indicating worse function. The distance covered in healthy adults 
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has been reported to range from 400 to 700 meters (Venkatesh et al., 2011). This study measured 
6-minute walk distance in meters.  
A substantial meaningful change in 6MWT walking distance score varies by chronic 
condition. A minimal clinically important difference is the score that reflects changes and has been 
estimated to be 34.4-54 meters. Specifically, in individuals with chronic obstructive pulmonary 
disease, a substantial change has been estimated to be 54 meters (Rasekaba, Lee, Naughton, 
Williams, & Holland, 2009), 50 meters in geriatrics (Perera, Mody, Woodman, & Studenski, 
2006), and 34.4 meters in stroke (Tang, Eng, & Rand, 2012). 
Psychometrics. Excellent test-retest reliability of 6MWT has been reported in a series of 
studies involving various disorders, in that correlation coefficients ranged from .98 to .99 with a 
30-minute rest in between (Skough, Broman, & Borg, 2013), .97 in cerebral palsy (Andersson, 
Asztalos, & Mattsson, 2006), .99 in knee osteoarthritis adults (Ateef, Kulandaivelan, & Tahseen, 
2016), and .96 to .98 in stroke (Wevers, Kwakkel, & Van De Port, 2011). Excellent interrater 
reliability of 6MWT has been reported in 37 participants with spinal cord injury (r = .99) 
(Scivoletto et al., 2011), .97 in 22 participants with spinal cord injury (Van Hedel, Wirz, & Dietz, 
2005). 
Appropriate predictive validity of 6MWT was estimated by correlating 6MWT with peak 
oxygen consumption (VO2) over time, in that moderate correlations were exhibited after 263 days 
(r = .71, p < .001) and after 381 days (r = 0.74, p < .001) in 113 patients with heart failure (Zugck 
et al., 2000). Another study demonstrated appropriate predictive validity of individuals with heart 
failure, in that a reduction in 6MWT walking distance predicted increased mortality in males and 
females (Steffen & Nelson, 2012). 
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Excellent concurrent validity was reported in individuals with Duchene’s muscular 
dystrophy with timed function tests (McDonald et al., 2013), with 2-minute walk test, and with 
12-minute walk test (r = .99) in individuals with stroke (Kosak & Smith, 2005). 
Good discriminant validity of 6MWT was demonstrated by poor correlation with body 
mass index (r = -.07) (Harada, Chiu, & Stewart, 1999). The content of 6MWT was evaluated by 
54 raters, and 37% of them reported 6MWT as valid (Jackson et al., 2008). The validity of 6MWT 
has not been previously reported in CKD Stage G5.  
Rationale behind using self-report and objective measures of fatigue. Fatigue is self-
reported by the individual through his subjective feelings. Being subjective, fatigue can be 
indirectly measured through various tools that asks participants about his feelings. This study 
utilized PFS-12 and PROMIS CAT fatigue as self-report tools to assess subjective fatigue. Other 
than self-report tools, fatigue can be observed through the performance of an individual in his daily 
activities. Reduced performance is observed in individuals on HD due to myriad reasons. This 
study utilized 6MWT to measure functional performance as an objective proxy measure of fatigue 
in individuals with HD. A combination of self-report and objective measures would provide more 
insight about an individuals’ fatigue experience by contributing towards data triangulation.  
Independent Variables (Appendix-A) 
Anemia. Serum hemoglobin levels were recorded from the medical records of the 
individual. On a routine basis, serum hemoglobin values are checked from blood drawn every two 
weeks in individuals on HD. Before the person is initiated on dialysis, venipuncture is performed 
by the nurse and blood is sent to the laboratory for hemoglobin measurement. Anemia is diagnosed 
if the serum hemoglobin falls below 13 grams per deciliter (g/dL) in males and below 12 g/dL in 
females (“Anemia in CKD | KDIGO,” 2012). 
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Dialysis adequacy. Dialysis adequacy was measured by Kt/V. K is dialyzer clearance, the 
rate at which blood passes through the dialyzer, t is for time and V is the volume of water a patient's 
body contains. The most recent Kt/V was obtained from the medical records of the patient. Since 
the blood test is done every month, we collected the blood records of the patient based on the 
month of interview with us. Patients with lower Kt/V have more health complications and a greater 
risk of death. A value of 1.2 and above is considered adequate dialysis (“Hemodialysis Dose & 
Adequacy | NIDDK,” 2014). 
Interdialytic weight gain. The amount of weight gained from the last dialysis session 
measured in pounds is considered as the interdialytic weight gain. The difference between last 
dialysis session weight and present pre-dialysis weight was determined from the medical records 
of the patient.  
Age, living status, employment status, gender and race. Information about these 
variables were collected using self-administered questionnaire from the participant. The variable 
age was an open-ended question. Living status was categorized to living with spouse/ 
siblings/parents/multiple relatives/ alone, total number of people in the family, number of adults 
in the house, number of children in house, number of senior citizens in the house, living in own 
house versus rented house versus apartment versus condominiums versus assisted living versus 
shelter homes versus others. Employment status was categorized to working full time/part 
time/contingent, number of jobs, number of days per week, number of hours per day.   
Comorbidities. Comorbidities refers to two or more disorders present in the same person. 
Comorbidities was measured by Charlson Comorbidity Index (CCI) (Appendix-A). CCI was 
developed by Mary Charlson in 1987 to predict mortality at 1 year due to specific disorders 
(Charlson, Pompei, Ales, & MacKenzie, 1987). CCI has been used in clinical research to predict 
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mortality, find confounding influence of comorbidities, and for self-report of comorbidities (De 
Groot, Beckerman, Lankhorst, & Bouter, 2003; Roffman, Buchanan, & Allison, 2016). There are 
17 comorbidities, with 2 subcategories for diabetes and liver disease. Each comorbidity is assigned 
a weight or a score from 1 to 6. All the scores are added up to get a total CCI score. The severity 
of comorbidity was categorized into three grades: mild, with CCI scores of 1–2; moderate, with 
CCI scores of 3–4; and severe, with CCI scores ≥5. The higher the score, greater are the chances 
of early mortality (Charlson et al., 1987). This measure is available free of cost and requires 
minimal training. The CCI has proven to be a reliable and valid measure across various studies. In 
individuals on dialysis, the inter-rater reliability of CCI was found to be excellent (r = .93) 
(Bernardini, Callen, Fried, & Piraino, 2004). Concurrent validity of CCI was supported by high 
correlation of comorbidity with other indices such as ICED (Index of Coexistent Diseases) ( r  =  
.58, p = .0001) (Gabriel, Crowson, & O’Fallon, 1999). Predictive validity was supported by reports 
showing that survival time decreased when the CCI score rates went up using Kaplan-Meier curve 
analysis in individuals with diabetic nephropathy (Huang et al., 2014).  
Data Analysis 
Research Question 1a: How severe was the level of behavioral, cognitive and affective 
fatigue pre and post dialysis? 
Descriptive statistics including measures of central tendency and standard deviation were used to 
describe the severity of behavioral, cognitive and affective fatigue. 
Research Question 1b: How frequently did the HD participants describe being fatigued? 
Descriptive statistics were used to describe the frequency. 
Research Question 1c: Did the mean fatigue score differ from U.S. and other chronic disease 
populations? 
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Independent t-test was used to test significant differences in fatigue scores. 
Research Question 1d: What was the trajectory of fatigue severity from pre-dialysis to post-
dialysis period? 
Dependent t-test were used to describe the trajectory of fatigue severity pre and post dialysis. 
Research Question 1e: What was the impact of fatigue on physical performance of HD 
participants pre and post dialysis? 
Dependent t-test were used to describe the impact of fatigue on physical performance. 
Hypothesis 2: There was no relationship between anemia, uremia, inter-dialytic weight gain, 
comorbidities and age with fatigue severity. 
Pearson’s correlation test/Spearman’s rank correlation was used to correlate physiological factors 
with fatigue severity. 
Hypothesis 3: There will be no significant difference in fatigue severity with respect to 
gender, race, marital status and employment. 
Chi square test was used to find significant difference in fatigue severity based on the select 
situational factors.  
Human Participants Protections 
This study recruited participants from 3 dialysis clinics in Southeast Michigan. 
Characteristics of the participants have been discussed in the inclusion/exclusion criteria section.  
Sources of Materials 
Information about the participants was collected from the medical records regarding the 
diagnosis, and other general health information. Questionnaires were used to collect information 
about their fatigue scores, & demographic information. The health information collected from the 
dialysis center were used for research purposes only. Coded ID numbers were used on all 
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questionnaires. Only the PI had access to participant identifiers. A master list with participant 
identifiers was prepared to keep track of the patients completing data collection as there were 
multiple encounters with the participants. 
Potential Risks and Protections 
There were no direct side effects associated with this study. However, there may have been 
chest pain, shortness of breath, leg cramps, staggering, diaphoresis and pale appearance while a 
6MWT was being performed, in the event of which the test would have been stopped and necessary 
medical intervention would have been provided by the BLS certified nurses or personnel in the 
clinic. The hallway where 6MWT was done had easy access to crash cart and an automated 
external defibrillator in case of any serious adverse events. Measures were taken to exclude 
participants who were at high risk for adverse events. In addition, the PI undertook BLS 
certification. 
Participation in this study may have increased a participant’s awareness of various 
symptoms in CKD, which may cause anxiety. Basic education, counseling, and emotional support 
to relieve anxiety were available from the PI. The risk for serious psychological distress from 
participation in this research was expected to be minimal. However, referrals for psychological 
support would have been made to a counselling clinic; but the payment of these services would 
have been the responsibility of the participants.  
A breach of confidentiality occurs if the signed consent form is not kept secure. Several 
safeguards to ensure privacy of data were undertaken. Coded ID numbers were used on the 
interview forms. All the instruments that were filled and completed were kept separately from the 
forms that were completed. No identifiers were kept except for the consent form. All paper records 
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were maintained in locked cabinet in a locked research office. In addition, published reports of 
results will not include participant identifiers.  
Participants were advised that they can withdraw their clinical data from the study analysis 
at any time without penalty. Following completion of this study, the medical records and the 
interview forms will continue to be stored. 
Potential Benefits of Research   
There was no direct benefit for participants in this research. However, the findings may 
enable health care providers to improvise treatment for patients who present with a high risk for 
fatigue. Findings will provide researchers with a better understanding of the pathophysiologic 
mechanisms underlying fatigue in HD patients that may lead to development of interventions in 
the future.  
Data and Safety Monitoring Plan 
Study Monitoring  
The dissertation committee members including 3 senior level researchers and a statistician 
along with the PI helped in monitoring the quality and standards of the research. A review was 
performed on a quarterly basis to determine attrition rates, documentation of any adverse events 
observed during fatigue assessment, and any missing data. This group kept an oversight of the 
study as well as considered factors external to the study when interpreting the data, such as 
scientific or therapeutic developments that may impact the safety of the participants or the ethics 
of the study. Any changes made in the protocol were reviewed by the advisor and information was 
sent to the IRB and the funding agency.  
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Security Procedures for Collection, Transfer and Storage of Electronic Data 
Electronic data included data collection instrument excel sheets, data sheets, recruitment 
information. All the computers used for the purpose of storing research related data were password 
protected. A password was required to log into Windows and then log into specific software. Data 
was entered into the SPSS 22 software in a personal secured computer. Electronic copies of forms 
were stored on a secure server with firewalls. The system used 128-bit encryption (SSL certificate) 
to transfer data between the machines. This technology is the same as that used for online e-
commerce applications to protect consumer information such as name, address, and credit card 
details. Also, the servers are scanned for viruses to detect attempts at unauthorized entry.  
Security Procedures for Collection, Transfer and Storage of Paper Data 
Paper files consisted of participant consents, completed participant assessment 
instruments. Double checking and spot checking was done during data entry. The data (hard copies 
of questionnaires) were stored in a safe place in a locked cabinet with the PI. All the paper copies 
of consent forms were kept separately from the completed study forms in the College of Nursing 
building.  
Identification of Adverse Effects 
Serious adverse events include death or any breach of confidentiality. In case of any 
adverse event that happened during the study would have been reported to the PI and the 
dissertation committee members within 24 hours. Subsequently the IRB would have been notified 
about the same. All the participants were provided with a telephone number to contact in case of 
any concerns. The necessary details of the adverse event would have been entered into the 
computer subsequently by the PI. The integrity of the study design was monitored as described 
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below, irrespective of the fact that the anticipation for any serious adverse event during the study 
is minimal.   
Quality Assurance of the Data 
A report was prepared regarding the key characteristics of the study participants, 
completeness and quality of data. The Dissertation Advisor was involved in checking the integrity 
of data storage, analyzing excessive number of “don’t know” responses. Project meetings took 
place on a need basis. These meetings addressed concerns and gave project updates.
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CHAPTER 4: RESULTS 
The purpose of this descriptive correlational study was to examine the severity and 
trajectory pattern of fatigue and delineate various physiological and situational factors that may 
influence fatigue severity in individuals with CKD Stage G5 on HD. Figure 5 shows the details 
about the enrollment of participants. Altogether 93 participants consented, 86 people completed 
the interviews pre-dialysis.  
A total of 27 individuals declined to participate of which 20 were not interested. From these 
20 individuals who were not interested in participating, 12 were receiving dialysis from Macomb 
Kidney Center, six were from Clinton Township and two from Partridge Creek dialysis center. A 
higher volume of patients (approximately 90 patients) receive dialysis at Macomb compared to 
Partridge Creek (approximately 40 patients) and Clinton Township (approximately 60 patients), 
and a higher number of individuals (n = 12) were not interested to participate from Macomb 
compared to the other two. There were no significant differences between the participants who 
participated (n = 86) and those who declined (n = 20), based on gender (χ2 = 1.94(1), p = .163). 
There were no significant differences between participants who participated (n = 86) and those 
dropped from the study (n = 7), based on gender (χ2 = .003, p = .959). 
The results from data analyses have been separated into 2 sections, Section 1, description 
of the sample and Section 2, results organized according to the specific aims, research questions 
and hypothesis.  
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Figure 5. Enrollment of individuals: sampling process 
Individuals approached for 
informed consent 
(n=120) 
Individuals who consented 
(n=93) 
Individuals meeting 
screening criteria 
(n=130) 
Screened individuals from 3 
dialysis clinics 
(n=160) 
Individuals completed 
interviews pre-dialysis 
(n=86) 
Individuals completed 
interviews post-dialysis 
(n=81) 
Individuals performed 6 -
minute walk test pre-dialysis 
(n=55) 
Individuals performed 6 -
minute walk test post-dialysis 
(n=44) 
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Description of the Sample 
Table 3 illustrates the frequency and percentages of demographic characteristics of the 
sample. Data were analyzed from a total of 86 participants who completed some measures in the 
study. The majority of the sample (90.7%, n = 78) were either African Americans (48.8%) or 
Caucasians (41.9%), with more males (n = 50) than females (n = 36). Most of the participants lived 
alone or with their spouses, while the remaining lived with their children, siblings, parents, and 
relatives. Most individuals owned their houses while others lived in an apartment, rented house, 
condo/townhome, and assisted living. Many of the individuals were not working or were retired.  
Table 4 illustrates the summary measures of demographic characteristics of the sample. 
The age of the sample ranged from 24 to 89 years, with a mean of 61.71 years (SD = 13.81, Mdn 
= 63.5). Majority (n = 53) of the individuals were less than 65 years of age, whereas lesser number 
(n = 33) belonged to age group greater than 65 years. Based on race who were less than 65 years, 
31 (36%) were African Americans, 22 (25.6%) were non-African Americans. Beyond 65 years of 
age, 11 (22.8%) were African Americans and 22 (25.6%) were non-African Americans. There was 
a significant difference in racial categories based on the two age groups, as evidenced by Chi-
square test (χ2 = 5.15(1), p = .023). There were four people in the household on an average, with 
two adults in the house. On an average, participants worked one day in a week.  
In terms of the site where participants were getting dialyzed, 44 individuals were from 
Clinton Township, 23 from Macomb, and 19 from Partridge Creek. Based on age groups, 25 
individuals (56.8%) were less than 65 years, whereas 19 (43.2%) were greater than 65 years of age 
at Clinton Township. At Macomb Kidney Center, there were 14 (60.9%) individuals lesser than 
65 years compared to 9 individuals (39.1%) who were beyond 65 years of age. At Partridge Creek, 
14 individuals (73.7%) were less than 65 years, whereas 5 people (26.3%) were beyond 65 years. 
51 
 
 
However, no significant differences were observed between these 3 sites, in terms on age groups 
(χ2 = 1.60(2), p = .448). There were no significant differences noted between the three sites, in 
terms of race (χ2  = 0.50(2), p = .779) and living status, (χ2 = 1.77(2), p = .411). 
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Table 3 
Frequency and Percentage of Demographic Characteristics (N=86) 
Variables Frequency Percentage 
Race   
Asian 1 1.2 
African American 42 48.8 
Caucasian 36 41.9 
Hispanic/Latino 2 2.3 
Other 5 5.8 
Gender   
Male 50 58.1 
Female 36 41.9 
Employment   
Fulltime 5 5.8 
Part-time 5 5.8 
Contingent 2 2.3 
Not working 74 86.0 
Number of jobs   
None 74 86.0 
One job 12 14.0 
Living status   
Spouse 21 24.4 
Siblings 3 3.5 
Parents 4 4.7 
Multiple relatives 4 4.7 
Alone 25 29.1 
Children/son/daughter 14 16.3 
Spouse and kids 8 9.3 
Spouse and siblings 3 3.5 
 Friends 4 4.7 
Living status   
Own house 38 44.2 
Rented house 10 11.6 
Apartment 20 23.3 
Condominium 9 10.5 
Assisted living 2 2.3 
Others 6 7.0 
Townhome 1 1.2 
Age   
More than 65 years 33 38.3 
Less than 65 years 53 61.6 
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Table 4 
Summary Measures of Demographic Characteristics 
Variables N Range Minimum Maximum Mean SD 
Age (years) 86 65 24 89 61.71 13.85 
No. of people in the family 86 16 0 16 4.27 2.99 
No. of adults in the house 86 6 0 6 1.78 1.47 
No. of children < 18 years in 
the house 
86 6 0 6 0.44 1.01 
No. of senior citizens in the 
house 
86 2 0 2 0.56 0.76 
No. of days working per week 86 7 0 7 0.56 1.58 
No. of hours working per day 86 12 0 12 1.03 2.90 
Note. SD=Standard Deviation, N=Number of subjects 
Table 5 shows the summary measures of physiological data collected in the study. The 
dialysis adequacy scores were adequate (>1.2) on average. The post-dialysis target weight of the 
individuals ranged from 53.5 kilograms to 162 kilograms, with an average of 90.8 kgs (SD = 
26.46). Individuals were anemic, both males and females on an average. A person with anemic 
kidney disease on hemodialysis is recommended erythropoietin injection intravenously at low dose 
if hemoglobin is below 10 gms/dL (“Anemia in Chronic Kidney Disease | NIDDK,” 2014). The 
patients were on dialysis treatment for 3 and 1/2 hours on an average.  
Among the individuals who completed 6-minute walk test, pre-dialysis and post-dialysis 
systolic blood pressure was high on an average, while diastolic blood pressure was mildly elevated. 
As shown in Table 6, the majority of the participants had arteriovenous fistula as their vascular 
access for dialysis treatment. 
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Table 5 
Summary Measures of Physiological Data 
Variables n Minimum Maximum Mean SD 
Dialysis adequacy (Kt/V) 85 0.98 2.03 1.48 0.21 
Serum hemoglobin       
Male  49 7.60 14.50 10.53 1.17 
Female 36 7.10 13.30 10.41 1.22 
Dialysis duration 86 150.00 300.00 216.62 25.68 
IDWG  84 -2.30 6.10 2.15 1.50 
Target weight  86 53.50 162.00 90.8 26.45 
Pre-dialysis parameters      
Weight 86 52.60 165.20 91.74 26.53 
SBP pre-walk 55 108.00 234.00 149.22 29.30 
DBP pre-walk 55 54.00 157.00 84.76 18.26 
Pre-walk HR 55 50.00 112.00 76.38 12.44 
Post-walk HR 52 59.00 130.00 88.06 18.21 
Post-dialysis parameters      
Weight 86 52.20 162.10 89.84 25.78 
SBP pre-walk 48 94.00 205.00 144.42 25.27 
DBP pre-walk 48 54.00 125.00 82.48 15.94 
Pre-walk HR 48 50.00 114.00 79.98 15.40 
 HR post walk 44 61.00 123.00 88.27 16.05 
Note. Weight in kilograms, hemoglobin in grams per deciliters, blood pressure in mm/Hg, Duration is in 
minutes, SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure, HR= Heart Rate in beats per 
minute, IDWG=Inter-dialytic weight gain, SD=Standard Deviation.  
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Table 6 
Frequency and Percentage of Physiological Data (N=86) 
Variables Categories Frequency Percentage 
Vascular 
access 
 
Arteriovenous fistula 61 70.9 
Arteriovenous graft 20 23.3 
Catheter-femoral/subclavian  5 5.8 
Comorbidity Moderate 11 12.8 
Severe 75 87.2 
 
 Analyses according to Specific Aims and Research Questions 
Specific Aim 1: To describe the severity and trajectory pattern of fatigue severity in 
individuals on HD. 
Research Question 1a: How severe was the level of sensory, behavioral, cognitive and 
affective fatigue before and after dialysis? 
 In the Piper Fatigue Scale, there are four subscales namely, behavioral, affective, sensory 
and cognitive. Each individual subscale score is obtained by adding the 3 specific item scores 
belonging to that subscale. Since each item has a score from 0 to 10, the total scores for the 
subscales can range from 0 to 30. Severe fatigue ranges from 21 to 30 based on PFS subscale 
scores. In this study, the scores from each subscale items were added up to get a total score for 
each subscale. Table 7 illustrates the summary measures of the subscales in the pre-dialysis and 
post-dialysis period.  Moderate affective fatigue was the highest type reported in the pre-dialysis 
period, while moderate affective and moderate sensory types were reported in the post-dialysis 
period. Mild cognitive fatigue was reported during pre-dialysis and post-dialysis period.  There 
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were significant differences between various types of fatigue subscales pre and post-dialysis, a 
detail of which is provided later in Table 12. 
Table 7 
Summary Measures of Fatigue Types Based on Piper Fatigue Scale 
Variables Pre-dialysis  Post-dialysis 
N Mean SD Maximum  N Mean SD Maximum 
Behavioral fatigue 86 13.79 8.66 30  81 13.86 9.55 30 
Affective fatigue 86 15.24 9.07 30  81 14.27 9.60 30 
Sensory fatigue 86 11.32 8.64 30  81 14.31 9.28 30 
Cognitive fatigue 86 6.29 5.98 26  81 7.86 6.57 28 
Note. The minimum score was 0 for all the subscales. SD= Standard Deviation, N= Sample  
The total score from each PFS subscale ranges from 0 to 30. Based on original PFS-12 
scoring, the subscale score ranges between 1 to 3 in ‘mild’ fatigue, 4-6 in ‘moderate’ fatigue and 
7 to10 in ‘severe’ fatigue. When multiplied by 3 items based on number of items in each subscale, 
these scores range from 3 to 9, 12 to 18, and 21 to 30, in ‘mild’, ‘moderate’ and ‘severe’ fatigue 
respectively. Clearly, some of the scores are not accounted for such as 1, 2, 10, 11, 19, 20 are not 
part of the range. That’s why, a new categorization was done to account for the scores that lie in 
between. Please note that we have reclassified the categories of PFS from those previously 
established (Reeve et al., 2012). In this study, the score obtained from individual PFS subscales 
was categorized to 4 groups, namely, no fatigue with score of 0, mild fatigue with score from 1 to 
10, moderate fatigue for a score of 11 to 20, and severe fatigue for a score of 21 to 30. Results 
shown in Table 8 were obtained using same process. Table 8 shows the frequencies of various 
types of fatigue and fatigue severity in the pre-dialysis and post-dialysis period. From the subjects 
who reported affective and behavioral fatigue, majority of the people were in the ‘moderate’ 
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category. From those who reported sensory and cognitive fatigue, a majority were in the ‘mild’ 
category. A total of 81 people completed the PFS post-dialysis. Most reported only severe affective 
fatigue (n = 26), mild sensory (n = 27), mild cognitive (n = 39) and mild behavioral fatigue (n = 
29). Few patients reported no sensory fatigue (n = 5) & no behavioral fatigue (n = 6). Based on 
proportions, a total of 90% people reported affective fatigue, 85% had sensory fatigue, 75% had 
cognitive fatigue and 89% had behavioral fatigue pre-dialysis. In the post-dialysis period, 85% had 
affective fatigue, 94% had sensory fatigue, 82% had cognitive fatigue and 93% had behavioral 
fatigue. 
Table 8 
Frequency of Fatigue Types & Severity Based on Piper Fatigue Scale  
Severity 
of fatigue 
Affective fatigue Sensory fatigue Cognitive fatigue Behavioral fatigue 
Frequency Percent Frequency Percent Frequency Percent Frequency Percent 
Pre-Dialysis 
None 9 10.5 13 15.1 21 24.4 10 11.6 
Mild 16 18.6 34 39.5 48 55.8 22 25.6 
Moderate 34 39.5 21 24.4 14 16.3 33 38.4 
Severe 27 31.4 18 20.9 3 3.5 21 24.4 
Total 86 100.0 86 100.0 86 100.0 86 100.0 
Post-Dialysis 
None 12 14.8 5 6.2 15 18.5 6 7.4 
Mild 22 27.2 27 33.3 39 48.1 29 35.8 
Moderate 21 25.9 26 32.1 23 28.4 24 29.6 
Severe 26 32.1 23 28.4 4 4.9 22 27.2 
Total 81 100.0 81 100.0 81 100.0 81 100.0 
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Research Question 1b. How frequently did the participants on HD describe being fatigued? 
Table 9 presents the frequency of responses pre-dialysis based on the PROMIS question 
‘In the past 7 days, how often did you have to push yourself to get things done because of your 
fatigue?’ PROMIS-CAT for fatigue was administered pre-dialysis. A majority of the patients said 
that they had suffered from fatigue ‘sometimes’ in the past 7 days. Nearly 70% (n = 61) patients 
said that they had fatigue ‘often’ and ‘sometimes’ in the past 7 days.  Only 9% participants reported 
fatigue was present ‘always’ in the past 7 days. 
Table 9 
Frequency of Fatigue based on PROMIS Questionnaire  
Responses  Frequency Percent 
Never 9 10 
Rarely 8 9 
Sometimes 38 44 
Often 23 27 
Always 8 9 
 Total  86 100 
 
Research Question 1c. Did the mean fatigue score differ from U.S. and other chronic disease 
populations? 
A mean score of 50 with a standard deviation of 10 has been reported for most PROMIS 
instruments when administered to the U.S. general population. The mean severity of fatigue based 
on PROMIS was higher and significantly different from the average population of the U.S. (t = 
5.96 (85), p < .001).  
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A comparison of various fatigue scores in different disease populations (Broderick et al., 
2013; Cella et al., 2016) based on the PROMIS fatigue questionnaire is provided in Table 10. The 
mean pre-dialysis fatigue scores in this study were significantly higher than individuals with cancer 
(p < .001), and rheumatoid arthritis (p = .037). The mean fatigue score in this study was 
significantly lower than in individuals with congestive heart failure (p = .004), COPD exacerbation 
(p = .000), and major depressive disorder (p < .001) (Cella et al., 2016). 
Based on this study findings, a moderate significant correlation was obtained between 
PROMIS score and PFS total fatigue score pre-dialysis (r = .58, p = .000). A significant weak to 
moderate correlation was obtained between PROMIS fatigue scores and all pre-dialysis PFS 
subscales, affective (r = .45, p = .000), behavioral (r = .56, p = .000), sensory (r = .46, p = .000), 
and cognitive (r = .322, p = .000). These findings inform convergent validity of PFS-12. 
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Table 10 
Fatigue Score Based on PROMIS in this Study & Other Populations 
PROMIS 
fatigue 
version 
Disease n Mean Standard 
Deviation 
t-score(d.f.) p-value 
CAT Osteoarthritis 100 56.2 7.8 -.29(85) .765 
CAT CHF 60 58.8 10.4 -2.92(85) .004 
CAT COPD exacerbation 46 62.9 8.3 -7.06(85) <.001 
CAT COPD stable  79 56.1 8.6 -.19(85) .843 
CAT Back pain 218 56.7 9.4 -.8(85) .423 
CAT MDD 196 61.3 8.3 -5.45(85) <.001 
SF Cancer 310 52 7.6 3.94(85) <.001 
SF RA 521 53.8 8.8 2.12(85) .037 
CAT Chronic dialysisa 86 55.9 9.18 5.96 (85) <.001 
Note. Information adapted from (Broderick et al., 2013; Cella et al., 2016), CAT= Computer 
Administered Format, SF= Short Form, COPD= Chronic Obstructive Pulmonary Disorder, MDD= Major 
Depressive Disorder, RA= Rheumatoid Arthritis, d.f.=degrees of freedom, aCurrent study. 
Bold indicates p-value is significant 
 
Research Question 1d: What was the trajectory of fatigue severity from the pre-dialysis to 
the post-dialysis period? 
Table 11 shows the frequency of fatigue severity based on PFS before and after dialysis.  
Based on original PFS-12 scoring, the total scale score ranges between 1 to 3 in ‘mild’ fatigue, 4-
6 in ‘moderate’ fatigue and 7 to10 in ‘severe’ fatigue. When multiplied by 12 items based on 
number of items in the scale, these scores range from 12 to 36, 48 to 72, and 84 to 120, in ‘mild’, 
‘moderate’ and ‘severe’ fatigue respectively. Clearly, some of the total scale scores are not 
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accounted for such as 1-11, 37-47, 73-83 are not part of the range. That’s why, a new categorization 
was done to account for the scores that lie in between. The category cut-off points were rounded 
to closest 10s’. The new category cut-off points adopted were 0 to 10 for “no fatigue”, “mild” for 
score of 11 to 40, “moderate” for a score of 41 to 80, and “severe” for a score of 81 to 120. As 
shown in Table 11, most individuals reported moderate fatigue pre-dialysis which was 
significantly different than the number of individuals who reported none, mild, moderate or severe 
fatigue, based on chi square test for difference in proportions. After dialysis, most individuals 
reported moderate fatigue with no significant difference in fatigue levels.  
Also, Table 11 shows the prevalence of patients who reported being fatigued versus not 
fatigued. Almost 90.7% (n = 78) of the patients were fatigued pre-dialysis whereas 84.6% (n = 69) 
of the patients were fatigued post-dialysis. However, please note that the number of patients 
increased in the “severe fatigue” category from 10.5% to 24.1% respectively. The proportion 
increase in ‘severe fatigue’ category was not significant from pre-dialysis to post-dialysis period 
based on McNemar’s test (p = .289). 
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Table 11 
Fatigue Severity Based on Piper Fatigue Scale Pre-dialysis & Post-dialysis 
Severity of fatigue Pre-dialysis fatiguea Post-dialysis fatigueb 
Frequency Percent Frequency Percent 
None 8 9.3 12 14.8 
Mild 27 31.4 23 28.4 
Moderate 42 48.8 26 32.1 
Severe 9 10.5 20 24.1 
Total 86 100.0 81 100.0 
Note. aχ2 = 36.7, d.f.= 3*, bχ2 = 5.37, d.f.= 3 
 *p-value is significant 
Based on the total raw score from adding the scores from 12 items of PFS, mean scores 
were obtained. As shown in Table 13, the mean scores of fatigue increased after dialysis. Despite 
the mean fatigue scores being higher post-dialysis, results from dependent/ paired t-tests found no 
statistical difference in total fatigue scores pre-dialysis and post-dialysis. In terms of different types 
of fatigue based on PFS, no significant differences were obtained in pre-dialysis versus post-
dialysis behavioral fatigue (t (80) = -.19, p = .843) and pre-dialysis versus post-dialysis affective 
fatigue (t (80) = -.87, p = .386).  A significant increase was noted in pre-dialysis sensory fatigue 
(M = 10.95, SD = 8.62) versus post-dialysis sensory fatigue (M = 14.30, SD = 9.28), based on 
dependent t-tests (t (80) = -3.06, p = .003). A significant increase (t (80) = -2.60, p = .011) in 
cognitive fatigue was noted pre versus post-dialysis as shown in Table 12. 
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Table 12 
Comparison of Mean Fatigue Scores Before & After dialysis Based on PFS  
Variables n Mean Standard 
deviation 
t-score 
(d.f.) 
p-value 
Pre-D total fatigue  81 45.74 25.80 -1.48 (80) .144 
Post-D total fatigue 81 50.30 31.62 
Pre-D behavioral fatigue 81 13.68 8.77 -0.19 (80) .843 
Post-D behavioral fatigue 81 13.86 9.55 
Pre-D affective fatigue 81 15.16 9.15 -0.87 (80) .386 
Post-D affective fatigue 81 14.27 9.60 
Pre-D sensory fatigue 81 10.95 8.62 -3.06 (80) .003 
Post-D sensory fatigue 81 14.30 9.28 
Pre-D cognitive fatigue 81 5.95 5.84 -2.60 (80) .011 
Post-D cognitive fatigue 81 7.86 6.57 
Note. d.f.=degrees of freedom, n=number of subjects, t=t-test, D=dialysis 
Bold=p-values are significant at .05 level. 
 
Research Question 1e: What was the impact of fatigue on physical performance of HD 
participants pre and post-dialysis? 
The three dialysis sites where walk tests happened had different course lengths due to 
limited space availability. The course length was 50 feet in two of the sites, whereas 71 feet in the 
third site. As seen in Table 13, based on dependent t-tests results, individuals walked significantly 
further during the 6-minute walk test before dialysis compared to post-dialysis. 
In terms of the patients’ vital signs, systolic blood pressure (t(47) = 1.86, p = .069) and 
diastolic blood pressure (t(47) = 1.29, p = .203) did not differ before and after dialysis. No 
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significant difference was observed in heart rate {t(41) = 0.41, p = .679}before walk pre-dialysis 
versus post-dialysis. A significant difference between heart rate pre walk and post walk done pre-
dialysis {t(51)= -5.52, p = .000}, oxygen saturation pre-walk and post-walk post-dialysis{t(51) = 
5.18, p = .000}. A significant difference was noted in oxygen saturation pre-walk and post-walk 
post dialysis {t(41) = 3.96, p = .000}, heart rate pre-walk and post-walk post dialysis {t(43)= -
3.55, p = .001}.  
Table 13 
Comparison of Mean 6MWD Before & After dialysis (n=44) 
Variables Mean Standard 
deviation 
t-score (d.f.) p-value 
Pre-dialysis 6MWD 290.22 90.22 2.45(43) .018* 
Post-dialysis 6MWD 273.96 89.54 
Note. 6MWD=6-minute walk distance, d.f.-degrees of freedom. 
 *p-value is significant at .05 level. 
 
Adding all the 12 items in PFS gives the total raw score. Participants who got a total raw 
score in PFS of 0 to 10 were recoded to a category of ‘no fatigue’ and those who got a raw score 
of 11 to 120 were recoded to a category of ‘fatigue present.’ Independent sample t-test was done 
to compare the mean 6MWD (6-minute walk distance) covered between these reclassified groups. 
Individuals who reported ‘no fatigue’ walked further compared to individuals who reported some 
level of fatigue (i.e. ‘fatigue present’). However, no significant difference was observed before or 
after dialysis as shown in Table 14 and Table 15. 
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Table 14 
Summary Measures of 6MWT Based on PFS Pre-dialysis (n=55) 
Fatigue severity n Mean of distance 
walked (meters) 
Standard 
Deviation 
t-score (d.f.) p-value 
No fatigue 4 316.04 151.96 .83 (53) .408 
Fatigue present 51 276.75 85.65 
Note. d.f.=degrees of freedom, n=number of subjects, t=Dependent t-test 
Table 15 
Summary Measures of 6MWT Based on PFS Post-dialysis (n=44) 
Fatigue severity n Mean of distance 
walked (meters) 
Standard 
Deviation 
t-score 
(d.f.) 
p-value 
Fatigue absent 6 291.84 112.11 .52 (42) .605 
Fatigue present 38 271.13 86.95 
Note. d.f.=degrees of freedom, n=number of subjects, t=Dependent t-test   
A correlation was obtained between total raw score derived from PFS and 6MWD. A weak 
but non-significant relationship was observed between fatigue score and distance walked pre-
dialysis (r = -.08, p = .567). A statistically significant inverse relationship was observed between 
fatigue score and distance walked in 6 minutes post-dialysis (r = -.32, p = .034). 
The mean pre-dialysis 6MWD covered was significantly lower {t = -23.89 (54), p < .001} 
in this study (279.61±90.45 meters, n = 55) when compared to overall mean walk distance of 
healthy subjects from seven different countries (571±90 meters, n = 444) (Casanova et al., 2011). 
The mean pre-dialysis 6MWD covered was significantly lower {t = -3.14 (54), p = .003} in this 
study (279.61±90.45 meters, n = 55) as compared to subjects with heart failure (318±106 meters, 
n = 64). 
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The 6MWD in pre-dialysis period did not correlate with PFS-12 total pre-dialysis (r = -
.07, p = .56), however, 6MWD in post-dialysis period significantly correlated, weakly with PFS-
12 total post-dialysis (r = -.32, p = .03). 
Specific Aim 2: Identify the extent to which selected physiological factors such as anemia, 
dialysis adequacy, inter-dialytic weight gain, co-morbidities and age influence fatigue 
severity in individuals with Stage G5 CKD on HD. 
Hemoglobin and Fatigue Severity 
The correlation between hemoglobin values and fatigue severity scores was negative in the 
pre-dialysis period and the p-value was statistically significant. The higher the hemoglobin, the 
lower the fatigue scores (r = - .24, p = .027). There was a weak, negative, non-significant relation 
between hemoglobin values and fatigue scores in the post-dialysis period (r = -.13, p = .250). A 
weak, inverse significant correlation was obtained between hemoglobin and pre-dialysis sensory 
fatigue (r = -.25, p = .020). A non-significant relation was observed with the other subscales of 
PFS pre-dialysis and hemoglobin, i.e. behavioral fatigue (r = -.12, p = .265), affective fatigue (r = 
-.20, p = .061), and cognitive fatigue (r = -.18, p = .095).  
Dialysis Adequacy and Fatigue Severity 
Dialysis adequacy was measured using recent Kt/V value from the medical records of the 
individual. A pre and post -dialysis urea blood sample is withdrawn every month in order to 
calculate the same. Since this value is assessed every month, this study used the Kt/V values from 
the same month patient was interviewed with us. The correlation between dialysis adequacy and 
pre-dialysis fatigue severity score was negative (r = -.21, p = .058) in the pre-dialysis period, and 
was trending towards statistical significance.  
Interdialytic Weight Gain and Fatigue Severity 
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Table 16 summarizes summary measures of interdialytic weight gain according to fatigue 
severity in the pre-dialysis period. Based on dependent t-tests, there was no statistically significant 
difference between the mean interdialytic weight gains and fatigue severity. As seen in Table 17, 
the means of interdialytic weight gain were not statistically different according to fatigue severity 
post-dialysis. 
Table 16 
Interdialytic Weight Gain Based on PFS Pre-dialysis (n=85) 
Fatigue severity n Mean of interdialytic 
weight gain (kgs) 
Standard 
Deviation 
t-score 
(d.f.) 
p-
value 
No fatigue 7 1.95 .64 -.34 
(83) 
.734 
Fatigue present 78 2.16 1.55 
Note. One patient record was missing in the dataset, that’s why number of subjects has one patient 
less compared to previous pre-dialysis data, d.f.=degrees of freedom, t=dependent t-tests 
 
Table 17 
Interdialytic Weight Gain Based on PFS Post-dialysis (n=80) 
Fatigue severity n Mean of interdialytic 
weight gain (kgs) 
Standard 
Deviation 
t-score 
(d.f.) 
p-
value 
No fatigue 11 2.34 1.19 .42 
(78) 
.676 
Fatigue present 69 2.13 1.56 
Note. One patient record was missing in the dataset, that’s why number of subjects has one patient 
less compared to previous post-dialysis data, d.f.=degrees of freedom, t=dependent t-tests  
 
Comorbidity and Fatigue Severity  
A total from all the items on the Charlson Comorbidity Index (CCI) was computed. Pearson’s 
correlation value was obtained between the CCI total and the total pre-dialysis PFS score. No 
significant correlation was found between comorbidity scores and fatigue scores pre-dialysis (r = 
.02, p = .791) and post-dialysis (r = .06, p = .581). The correlation between the PROMIS fatigue 
score and comorbidity score was statistically significant (r = .21, p = .05), but was weak in strength. 
The higher the comorbidities, the higher the fatigue score.  
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Age and Fatigue Severity 
There was a significant but weak inverse correlation between age and fatigue scores pre-
dialysis (r = -.26, p = .017) and post-dialysis (r = -.23, p = .034). Younger age was associated with 
a higher fatigue score or vice versa. Based on independent t-tests, no significant difference in pre-
dialysis fatigue severity {t(84) = .09, p = .922} and post-dialysis fatigue severity {t(79) = .98, p = 
.328} was observed between individuals who were less than 65 years and greater than 65 years of 
age. 
Regression of Physiological Factors on Fatigue Severity 
Multiple regression was done on the total raw scores obtained from PFS during the pre-
dialysis period. The independent variables were interdialytic weight gain (IDWG), hemoglobin, 
dialysis adequacy (Kt/V), age and CCI scores. Findings from multiple regression are shown in 
Table 18. The multiple regression coefficient, R indicates a moderate level of prediction. Adjusted 
R-square signifies the percentage of variance explained by the model. Based on adjusted R-square, 
about 16.7% of variance in total scores of fatigue severity is predicted by the physiological factors. 
The physiological factors significantly predicted pre-dialysis fatigue severity, F = 4.28 (5,77), p = 
.002. Among these physiological factors, hemoglobin, dialysis adequacy, and age significantly 
contributed to the model. Adding ‘age*race’ (p = .322) and ‘race’ (p = .358) to the model did not 
show any significance, which means that there was no interaction between age and race. Please 
note that these findings are not reported in Table 18. The equation to predict fatigue severity before 
dialysis is the following: 
Predicted pre-dialysis fatigue severity = 200.63 – 2.23 (IDWG) – 6.77 (Hb) – 31.75 (Kt/V) 
– 0.52 (Age) + 0.22 (CCI) 
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Table 18 
Regression: Influence of Physiological Factors on PFS Pre-dialysis (n=83) 
Predictors B values S.E. B. Beta t-value p-value 
Constant  200.63 36.29  5.53 <.001 
IDWG -2.23 1.78 -0.13 -1.25 .216 
Hemoglobin (Hb) -6.77 2.18 -0.32 -3.10 .003** 
Dialysis adequacy (Kt/V) -31.75 12.37 -0.27 -2.57 .012* 
Age -0.52 0.19 -0.29 -2.71 .008** 
Comorbidity (CCI) 0.22 1.22 0.02 0.18 .855 
R2 
Δ R2 
F 
0.22 
0.16 
4.28** 
Note. IDWG=Interdialytic Weight Gain, B=unstandardized coefficients, SE B=standard error of 
unstandardized coefficients, R2=Multiple regression coefficient, Δ R2=Adjusted R2 
* p value is significant at .05 level 
** p value is significant at .01 level 
 
Table 19 shows the findings from multiple regression that was done on total raw scores 
obtained from PFS post-dialysis. The physiological variables were the independent variables. Only 
4% of variance in total scores of fatigue severity was predicted by physiological factors post-
dialysis. Age was contributing significantly to the model, p = .029. However, the model was not 
statistically significant, F = 1.732(5,74), p = .138. The equation to predict fatigue post-dialysis is: 
Predicted post-dialysis fatigue severity=153.51- 0.50 (IDWG) – 4.02 (Hb) -20.91 (Kt/V) - 
0.57 (Age) +0.97 (CCI) 
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Table 19 
Regression: Influence of Physiological Factors on PFS Post-dialysis (n=80) 
Predictors B 
values 
S.E. B. Beta t-value p-value  
Constant 153.51 48.32  3.17 .002  
IDWG -0.50 2.39 -0.24 -0.21 .837  
Hemoglobin (Hb) -4.02 2.88 0.15 -1.39 .169  
Dialysis adequacy (Kt/V) -20.91 16.72 -0.14 -1.25 .215  
Age -0.57 0.25 -0.25 -2.22 .029*  
Comorbidity (CCI) 0.97 1.62 0.06 0.59 .552  
R2 
Δ R2 
F 
0.10 
0.04 
1.73 
 
Note. IDWG=Interdialytic Weight Gain, B=unstandardized coefficients, SE B=standard error of 
unstandardized coefficients, R2=Multiple regression coefficient, Δ R2=Adjusted R2 
* p value is significant at .05 level. 
 
Specific Aim 3: Identify the extent to which select situational factors such as living status, 
employment, gender, and race influence fatigue severity in individuals with Stage G5 CKD 
on HD. 
The variable ‘race’ was recoded to two categories, ‘African Americans’ and ‘Non-African 
Americans’; ‘living status’ to ‘living alone’ versus ‘living with someone’, employment status to 
‘working’ and ‘not working.’ The total scores from adding 12 items on PFS are put into four 
categories, namely, “no fatigue” with a score of 0 to 10, “mild fatigue” for a score of 11 to 40, 
“moderate fatigue” for a score of 41 to 80, “severe fatigue” for a score of 81 to 120.   
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Living Status and Fatigue Severity 
As seen in Table 20, living status and fatigue severity are significantly associated (p = .003). 
As shown in Figure 6, more people living with someone were moderately fatigued compared to 
people who lived alone. All the patients who lived alone reported fatigue. 
Table 20 
Association between Living Status and Fatigue Severity in Pre-dialysis Period (N=86) 
Living status No fatigue Mild fatigue Moderate fatigue Severe fatigue 
Living with someone 8 (9.3%) 13 (15.1%) 35 (40.7%) 5 (5.8%) 
Living alone 0 14(16.3%) 7 (8.1%) 4 (4.7%) 
Note. χ2 = 14.24, d.f.= 3, p = .003* 
 *p-value is significant 
 
 
Figure 6. Bar chart: living status by fatigue severity in pre-dialysis 
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Table 21 and Figure 7 shows the association between living status and fatigue severity in 
the post-dialysis period, and the Chi- square value was not significant at .05 level. People who 
lived alone reported similar fatigue severity compared to people who lived with someone post-
dialysis. 
Table 21 
Association between Living Status and Fatigue Severity in Post-dialysis Period (n=81) 
Living status No fatigue Mild fatigue Moderate fatigue Severe fatigue 
Living with someone 10(12.3%) 15(18.5%) 19(23.5%) 13(16%) 
Living alone 2(2.5%) 8(9.9%) 7(8.6%) 7(8.6%) 
Note. χ2 =1.62(3), p = .653 
 
Figure 7. Bar chart: living status by fatigue severity in post-dialysis 
Employment Status and Fatigue Severity 
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As seen in Table 22 and Figure 8, the association between employment status and fatigue 
severity in pre-dialysis period was not statistically significant, however, the p-value was trending 
towards significance. People who were ‘not working’ reported similar fatigue severity compared 
to people who were working ‘pre-dialysis’.  
Table 22 
Association Between Employment and Fatigue Severity Pre-dialysis (N=86) 
Employment No fatigue Mild fatigue Moderate fatigue Severe fatigue 
Not working 7(8.1%) 26(30.2%) 32(37.2%) 9(10.5%) 
Working 1(1.2%) 1(1.2%) 10(11.6%) 0 
Note. χ2 =7.23(3), p = .065 
 
 
Figure 8. Bar chart: employment status by fatigue severity pre-dialysis  
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As seen in Table 23 and Figure 9, association between employment status and fatigue 
severity in post-dialysis period was not statistically significant. People who were ‘not working’ 
reported similar fatigue severity compared to people who were working post-dialysis. All people 
who were ‘working’ reported fatigue in the post-dialysis period, however, not significant. 
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Table 23 
Association between Employment and Fatigue Severity Post-dialysis (N=81) 
Employment  No fatigue Mild fatigue Moderate fatigue Severe fatigue 
Not working 12(14.8%) 20(24.7%) 21(25.9%) 17(21%) 
Working 0 3(3.7%) 5(6.2%) 3(3.7%) 
Note. χ2 =2.63(3), p = .452 
 
Figure 9. Bar chart: employment status by fatigue severity in post-dialysis period 
Gender and Fatigue Severity 
Table 24 and Figure 10 presents the association between gender and fatigue severity in the 
pre-dialysis period, and the chi-square value was not statistically significant. Males and females 
reported similar fatigue severity in pre-dialysis period. 
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Table 24 
Association between Gender and Fatigue Severity Pre-dialysis (N=86) 
Gender No fatigue Mild fatigue Moderate fatigue Severe fatigue 
Male 7(8.1%) 15(17.4%) 23(26.7%) 5(5.8%) 
Female 1(1.2%) 12(14%) 19(22.1%) 4(4.7%) 
Note. χ2 = 3.12(3), p = .372 
 
Figure 10. Bar chart: gender by fatigue severity in pre-dialysis period 
Table 25 and Figure 11 presents the association between gender and fatigue severity in the 
post-dialysis period, and the Chi-square value was not significant at .05 level. Males and females 
reported similar fatigue severity in post-dialysis period. 
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Table 25 
Association between Gender and Fatigue Severity Post-dialysis (N=81) 
Gender No fatigue Mild fatigue Moderate fatigue Severe fatigue 
Male 9(11.1%) 13(16%) 15(18.5%) 9(11.1%) 
Female 3(3.7%) 10(12.3%) 11(13.6%) 11(13.6%) 
Note. χ2 =2.76(3), p = .429 
 
Figure 11. Bar chart: gender by fatigue severity in post-dialysis period 
Race and Fatigue Severity 
As seen in Table 26 and Figure 12, the association between race and fatigue severity is not 
statistically significant in the pre-dialysis period. African Americans and non-African Americans 
reported similar fatigue severity. 
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Table 26 
Association between Race and Fatigue Severity Pre-dialysis (N=86) 
Race No fatigue Mild fatigue Moderate fatigue Severe fatigue 
AA 4(4.7%) 13(15.1%) 21(24.4%) 4(4.7%) 
Non-AA 4(4.7%) 14(16.3%) 21(24.4%) 5(5.8%) 
Note. χ2 = .1(3), p = .992, AA=African Americans 
 
Figure 12. Bar chart: race by fatigue severity in pre-dialysis period 
Table 27 and Figure 13 presents the association between race and fatigue severity in the 
post-dialysis period, and the chi-square was not statistically significant at .05 level. African 
Americans and Non-African Americans reported similar fatigue severity in the post-dialysis 
period.   
  
79 
 
 
Table 27 
Test of Association between Race and Fatigue Severity Post-dialysis (N=81) 
Race No fatigue Mild fatigue Moderate fatigue Severe fatigue 
AA 6(7.4%) 12(14.8%) 10(12.3%) 12(14.8%) 
Non-AA 6(7.4%) 11(13.6%) 16(19.8%) 8(9.9%) 
Note. χ2 = 2.21(3), p = .529, AA: African Americans 
 
Figure 13. Bar chart: race by fatigue severity in post-dialysis period 
Regression of Situational Factors on Fatigue Severity 
The variables ‘race’ was recoded to two categories, ‘African Americans’ and ‘Non-African 
Americans’; ‘living status’ to ‘living alone’ versus ‘living with someone’, employment status to 
‘working’ and ‘not working.’ The dependent variable, fatigue severity was recoded to two 
categories, ‘fatigue absent’ and ‘fatigue present.’  A logistic regression was done to study the 
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influence of situational factors such as race, gender, living status and employment status on fatigue 
severity (dependent variable). Table 28 presents findings from logistic regression in the pre-
dialysis period. The logistic regression model was statistically significant, χ2 = 10.77(4), p = .029. 
None of the independent variables such as race, gender, living status and employment status added 
significantly to the model, however, gender was trending towards significance. Males were 7.31 
times more likely to be fatigued severely compared to females, pre-dialysis. 
Table 28 
Regression: Influence of Situational Factors on Fatigue Severity Pre-Dialysis 
Factors B values B (Exp) Significance 
Race .44 1.55 .582 
Living status -19.6 0 .998 
Employment status .56 1.75 .628 
Gender 2 7.31 .073 
R2 .255 
Note. χ2 = 10.77(4), p = .029  
A logistic regression was done to study the influence of situational factors such as race, 
gender, living status and employment status on fatigue severity (dependent variable). Table 29 
presents findings from logistic regression in the post-dialysis period. The logistic regression model 
was not statistically significant, χ2 = 8.84(4), p =.065, but was trending. None of the independent 
variables such as race, gender, living status and employment status added significantly to the 
model, however, gender was trending. Males were 3.36 times more likely to be fatigued severely 
than females in the post-dialysis period. Please note the odds ratios or B(Exp) have reduced from 
pre-dialysis to the post-dialysis period. 
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Table 29 
Regression: Influence of Situational Factors on Fatigue Severity Post-Dialysis 
Factors B values B (Exp) Significance 
Race .06 1.07 .924 
Living status -1.2 .3 .157 
Employment status 20.04 - .999 
Gender 1.21 3.36 .097 
R2 .182 
Note.  χ2 = 8.84(4), p = .065  
Summary  
Almost 90% reported fatigue pre-dialysis, and 85% reported fatigue post-dialysis. Based 
on different types of fatigue, a total of 90% people reported affective fatigue, 85% had sensory 
fatigue, 75% had cognitive fatigue and 89% had behavioral fatigue pre-dialysis. In the post-dialysis 
period, 85% had affective fatigue, 94% had sensory fatigue, 82% had cognitive fatigue and 93% 
had behavioral fatigue.  
Based on the levels of fatigue as categorized by PFS-12, 31.4% were mildly fatigued pre-
dialysis, 28.4% were mildly fatigued post-dialysis. Almost 50% were moderately fatigued pre-
dialysis, 32% fatigued post-dialysis. And severely fatigued were 10% pre-dialysis, whereas 24% 
were severely fatigued post-dialysis. 
Based on the frequency of fatigue as defined by PROMIS-fatigue, 44% were fatigued 
‘sometimes’ in the past 7 days, and 36% were fatigued ‘often’ and ‘always’ in the past 7 days. The 
fatigue severity was higher than the general U.S. population based on PROMIS-fatigue. The 
fatigue severity in the current study was higher than patients with cancer and rheumatoid arthritis, 
and was lower than patients with heart failure, depression and COPD exacerbation. 
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Based on the 6MWT, patients walked significantly less post-dialysis than they did pre-
dialysis. Based on PFS-12, the mean fatigue scores increased from pre-dialysis to post-dialysis 
period, however, was not statistically significant. 
Among the influencing factors, many physiological factors were associated with fatigue 
severity. Age was correlated weakly to fatigue severity pre-dialysis and post-dialysis. Hemoglobin 
values and dialysis adequacy were correlated with fatigue severity in the pre-dialysis period. 
Comorbidities were associated with PROMIS fatigue. From multiple regression, age, dialysis 
adequacy and hemoglobin significantly predicted fatigue severity pre-dialysis. After dialysis, only 
age significantly predicted fatigue severity.  
Among the situational factors, more people living with someone reported fatigue compared 
to people who were living alone. From findings of the regression analyses, none of the situational 
variables predicted fatigue severity pre-dialysis or post-dialysis. However, gender was trending 
towards significance. Males were more likely to be fatigued severely compared to females before 
and after dialysis. 
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CHAPTER 5: DISCUSSION 
The purpose of this study was to examine the severity and trajectory pattern of fatigue and 
delineate various physiological and situational factors that may influence fatigue severity in 
individuals with CKD Stage G5 on HD. The discussion is according to the aims and research 
questions. 
 This study was done in subjects on hemodialysis treatment. The chronic and frequent 
nature of the treatment makes these patients unique, as they come for HD treatment every 2-3 days 
per week in an outpatient dialysis clinic. Due to this frequency of visits, the follow-up and 
availability of subjects becomes very easy as a researcher. And the volume of patients seen by a 
dialysis clinic remains stable for a long period of time, since dialysis is a chronic treatment most 
of the times.  
This study was conducted in multiple DaVita dialysis sites. DaVita has a chain of dialysis 
clinics with supported infrastructure and guidelines for conducting research, that makes ‘gaining 
entry’ into the clinic easier. There were no significant differences in the subject population in terms 
of age, gender and race. However, there were a few differences between the three sites, such as, 
volume of patients being dialyzed at a clinic, volume of patients interested in participating in the 
study, and course length that was used for the 6-minute walk test. 
This is the first study to report 6MWT results on a dialysis day, before and after dialysis. 
Studies conducted in the past have utilized 6MWT to measure physical performance or on a non-
dialysis day. And therefore, a real-time assessment of physical fatigue before and after dialysis has 
been done for the first time. 
This study had 55 individuals who performed 6MWT before dialysis and 44 walked after 
dialysis. Most patients who gave approval to walk were walking daily either to do chores or for 
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work. Most patients were interested or motivated to do the walk test. There were subjects who had 
stigma attached to the word “walk” and thought of it as a stress test or physical exertion test. On 
explaining further, they agreed. Some individuals were reluctant to walk due to reasons such as 
work and transportation. Some individuals walked before dialysis, however, could not walk post-
dialysis due to feeling sick, pain in legs, feeling dizzy, cramping and tiredness. There were a few 
individuals who walked with prosthetic device, tracheostomy, and walkers.  
PROMIS-CAT fatigue was used for the first time in dialysis individuals in this study, and 
therefore, is a significant contribution to the body of evidence. The measure was easy to administer, 
the user requires a registration with the Red Cap software. Patients were able to understand the 
questions, and more questions were administered to the individuals by the computer in case 
patients did not answer appropriately. The computer itself picks questions from the PROMIS item 
bank based on the responses given. However, the number of questions administered varied person 
to person which makes analysis difficult. A T-score in the end determines the intensity or severity 
of fatigue. The other dimensions such as frequency and duration are measured through individual 
questions in the questionnaire, however, the multidimensionality does not get reflected in the end 
on analysis, and researcher has to search for questions that could be answering a specific dimension 
for analysis purposes. More clarity is needed in this area of PROMIS-CAT fatigue measure. 
The PFS-12 was administered to individuals before and after dialysis to measure their 
current levels of fatigue for the first time in this study. To our knowledge, previous study that has 
utilized PFS used a longer version of the questionnaire with 22-27 items and was administered 
post-dialysis only. PFS-12 had excellent reliability in this study and measured various subtypes of 
fatigue. We also found a significant inverse weak correlation of PFS-12 with 6-minute walk 
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distance post-dialysis. Therefore, PFS-12 could be an excellent measure of examining physical 
fatigue as well.  
Aim 1: Examine severity and trajectory pattern of fatigue in individuals with Stage G5 CKD 
on HD. 
Research Question 1a: How severe was the level of sensory, behavioral, cognitive and 
affective fatigue before and after dialysis? 
In this study, participants reported moderate severity of affective, sensory and behavioral 
fatigue, and mild cognitive fatigue. A significant difference was noted before and after dialysis, in 
terms of cognitive and sensory fatigue, whereas no significant difference was seen in behavioral 
and affective fatigue pre and post-dialysis.  
Among the various types of fatigue subscales according to Piper Fatigue Scale, moderate 
‘affective fatigue’ scores were reported before and after dialysis session in this study. Almost 90% 
patients had affective fatigue pre-dialysis and 85% had affective fatigue post-dialysis. A previous 
investigator who did a qualitative study in patients on HD reported ‘affective fatigue’ as an 
overarching subtheme in the  findings (Lee et al., 2007). However, a before and after dialysis 
assessment of fatigue was missing in that study. Thus, our findings confirm findings from Lee 
(2007), and add to the evidence of ‘affective fatigue’ being present in the pre-dialysis period. 
The present study found moderate ‘sensory fatigue’ scores with a significant increase in 
scores post-dialysis compared to pre-dialysis period. Almost 85% had sensory fatigue pre-dialysis 
and 94% had sensory fatigue post-dialysis. The ‘sensory fatigue’ subscale in PFS is similar to 
‘physical fatigue’ described in qualitative studies by Horrigan (2013) and Lee (2007). During 
dialysis, there are fluid shifts and other exchanges of small molecules and ions that happen and 
cause physical symptoms. There is a decline in energy and strength (Horigan et al., 2013). Some 
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patients described after dialysis, ‘it felt as if life was taken from me’ (Lee et al., 2007). Karakan 
(2011) did a quantitative study that has reported ‘sensory fatigue’ in HD subjects after dialysis 
treatment. Sensory PFS scores were 21% mild, 37% moderate, and 42% severe in that study 
(Karakan et al., 2011). Post-dialysis sensory fatigue was 33.3% mild, 32.1% moderate and 28.4% 
severe in our study. Presence of sensory fatigue pre-dialysis has not been studied in the past, and 
this study is the first to report the same.  
This study found mild ‘cognitive fatigue’ in pre and post-dialysis sessions, with a 
significant increase in cognitive fatigue after dialysis. Almost 75% reported cognitive fatigue pre-
dialysis and 82% had cognitive fatigue post-dialysis. No other studies have done a comparison of 
cognitive fatigue pre and post-dialysis. Lee (2007) described ‘cognitive fatigue’ as an important 
domain in her qualitative study on 14 patients on HD and is a decline in cognitive function. Patients 
had intentional isolation, regretted lost cognition and tried to cope with cognitive fatigue. Horrigan 
(2013) mentioned ‘mental fatigue’ as an overarching subtheme in individuals on dialysis. Patients 
in that study had difficulty in remembering names and details they knew for a long time. A low 
‘mental fatigue’ score was reported in another quantitative study (Biniaz et al., 2013). Both ‘mental 
fatigue’ and ‘cognitive fatigue’ seem to be overlapping in features and needs further investigation. 
A weak non-significant correlation was observed between hemoglobin and cognitive fatigue in 
this study, that was trending towards significance. Anemia could be a causative factor for cognitive 
fatigue or cognitive impairment (Patel, Dasgupta, Tadros, & Baharani, 2016), as evidenced by 
Karakan et al (2011).  Some theories suggest ‘dialysis disequilibrium’ that leads to cerebral edema, 
and causes reduction in cognitive function (Patel et al., 2016). Cognitive fatigue happens due to 
low serum glucose, high serum urea and C-reactive protein levels, that leads to cerebral 
disintegration and cognitive dysfunction eventually (Karakan et al., 2011). Investigators have 
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shown an increase in C-reactive protein levels in 454 individuals on HD with reduced cognitive 
function (Watanabe et al., 2016). This study did not examine serum markers and is an area for 
further investigation. 
Research Question 1b: How frequently did the HD participants describe being fatigued? 
This study utilized PROMIS-CAT fatigue in dialysis population for the first time. In 
response to the PROMIS question ‘how often did you have to push yourself to get things done 
because of your fatigue in the past seven days?’, almost 70% (n = 61) patients said that they had 
fatigue ‘often’ or ‘sometimes’ in the past seven days. These responses indicate that participants 
are frequently fatigued. There are no previous studies that have reported data on frequency of 
fatigue in dialysis population to our knowledge. Dialysis treatment happened 2-3 times in a week, 
and this study shows that patients are fatigued before and after dialysis. These findings support 
qualitative data from Horigan and Barroso (2016), in which the combination of continuous fatigue 
and acute fatigue after dialysis creates a vicious circle of fatigue. Thus, patients are never ‘fatigue-
free’ in a week. Before they recover from the past dialysis treatment, it’s time for another dialysis 
treatment (Horigan & Barroso, 2016).  
Research Question 1c: Did the mean fatigue score differ from US and other chronic disease 
populations? 
The mean fatigue score was higher and was significantly different from the average 
population of U.S., and was significantly higher than individuals with cancer, and rheumatoid 
arthritis (Cella et al., 2016). The mean fatigue score in this study was significantly lower than 
individuals with congestive heart failure, COPD exacerbation, and major depressive disorder 
(Cella et al., 2016). 
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The current study had higher mean fatigue scores compared to patients with congestive 
heart failure (Cella et al., 2016). Cytokines are responsible for fatigue, cognitive fatigue and 
depression (Karshikoff, Sundelin, & Lasselin, 2017; Lasselin & Capuron, 2014). Levels of 
cytokines such as C-Reactive Protein are much higher in patients on dialysis and range from 5 to 
50 ng/ml, whereas in cardiovascular disease, the levels are much lower and range between 1 to 3 
ng/ml (Kovesdy, Joel, & Zadeh, 2017). Based on this finding, one would expect higher fatigue 
scores in dialysis patients. However, contrasting findings found in this study could be due to 
majority of the subjects were from a younger age group and subjects living with someone.  
In cancer, cytokines lead to cytokine-induced sickness behavior, however, an investigator 
found that these cytokines are related to physical fatigue and not mental fatigue (de Raaf et al., 
2012). The current study found both types of fatigue, physical and cognitive in patients on dialysis. 
Perhaps, the higher fatigue scores in this study are reflective of both types of fatigue present in the 
dialysis population. No studies have compared different qualities of fatigue present in cancer, and 
therefore to draw a necessary hypothesis is difficult.   
Research Question 1d: What was the trajectory of fatigue severity from the pre-dialysis to 
the post-dialysis period?  
In terms of prevalence, nearly all of the patients (90.7%) in this sample were fatigued pre-
dialysis whereas a lesser number, but still a majority of the patients (84.6%) were fatigued post-
dialysis. The intensity increased in the ‘severe fatigue’ category from 10.5% to 24.1%. However, 
no significant difference was observed pre versus post-dialysis. These findings are similar to 
Biniaz and colleagues (2013) who reported that all the patients on HD, with a mean age of 61 years 
(SD = 12.61 years), complained of fatigue. However, a description of comorbidities is missing in 
the study. Other investigators have reported a lower prevalence of fatigue in HD. Zyga and 
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colleagues (2015) reported prevalence of fatigue to be 62%, with a mean age of 56 years (Zyga et 
al., 2015). Another investigator reported 65% fatigue in patients on HD post-dialysis (Karakan et 
al., 2011). However, Karakan and colleagues did not include subjects who had co-morbidities, and 
the median age of subjects in that study was 55 years compared to the mean age of 61 years (Mdn 
= 63.5 years) in the current study. In this study, majority of the subjects (n = 53) were less than 65 
years of age, with no significant difference in fatigue severity between individuals less than and 
greater than 65 years of age. Our study found an inverse relation between fatigue severity levels 
and age. Therefore, it can be postulated that the high prevalence of fatigue in the current study 
could be due to patients with higher comorbidities. Based on Charlson Comorbidity Index, 87% 
patients had severe comorbidities in this study.  
In this study, most individuals had ‘moderate fatigue’ pre-dialysis. These findings are 
similar to Horigan & Barroso (2016) who reported temporal patterns of fatigue after dialysis. In 
that study, participants had continuous fatigue even after long hours of rest and sleep. Some 
participants who had ‘continuous fatigue’ never returned to a baseline but continued to have 
fatigue until the next day when they get started for another hemodialysis session (Horigan & 
Barroso, 2016). The same continuous fatigue extends to next day and is captured by pre-dialysis 
questionnaire in this study. No other studies have reported pre-dialysis fatigue and needs further 
investigation. 
 Post-dialysis, most individuals reported moderate fatigue in this study. Letchmi (2011) 
found 54% of the patients with high level of fatigue and 45.6% experienced a low level of fatigue. 
They used Multidimensional Fatigue Inventory that classified subjects to 2 categories of fatigue 
(Letchmi et al., 2011). In this study, Piper Fatigue Scale was used that classified subjects to 3 
categories, and therefore, the variable findings might be due to different types of fatigue 
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instruments used. The findings are contrasting with another investigator findings that utilized Piper 
Fatigue Scale and had 43% patients reporting severe fatigue post-dialysis (Karakan et al., 2011).  
The mean scores of fatigue increased after dialysis, however, there was no statistical 
difference between the mean scores in this study. Interestingly, this is the only study that reports a 
comparison of fatigue score before and after dialysis. Only 1 previous study compared ‘non-
dialysis’ and ‘dialysis day’ fatigue scores, in that there was increased fatigue severity on ‘dialysis 
day’ and an increase in fatigue intensity later in evening compared to morning or afternoon time 
(Abdel-Kader et al., 2014). Our study confirms these findings that fatigue gets worse later in the 
day after dialysis. Other investigators have reported post-dialysis fatigue scores or non-dialysis 
day fatigue scores (Horigan & Barroso, 2016; Karakan et al., 2011; Picariello, Moss-Morris, 
Macdougall, & Chilcot, 2018). Some investigators do not specifically report the timing of 
questionnaire administration in relation to timing of hemodialysis session (Zyga et al., 2015). This 
study reiterates the importance of diurnal variations of fatigue in the dialysis population. 
Research Question 1e: What was the impact of fatigue on the physical performance of HD 
participants pre and post dialysis? 
The current study examined motor fatigue using 6MWT and for the first-time patients 
performed walk test pre-dialysis and post-dialysis. No falls were reported during the walk in the 
study. Most patients completed walk test. Some patients had to lean on the wall to get their balance 
back, and some could not complete the walk due to feeling dizzy, breathlessness, pain in legs, back 
pain. Some individuals took breaks to rest during the walk and finished the walk at 6 minutes.  
In this study, individuals walked significantly further during 6-minute walk test before 
dialysis compared to post-dialysis. On an average, patients walked 290 meters before dialysis and 
273 meters after dialysis. Two studies were found that examined 6MWT results on patients on HD 
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and found that patients walked much further than those in the current study. However, the other 
studies did the walk test on non-dialysis days. Results from those studies indicated that patients 
walked 400-600 meters (Pajek et al., 2016)and 387.89 meters (Dziubek et al., 2016). 
Only one other study was found that conducted the walk test on dialysis day. Results from 
that study, 310 meters (Manfredini et al., 2017), are similar to results from the current study. The 
current study had subjects do walk-test 10 minutes before and after they were initiated and 
terminated on dialysis respectively. The present study adds to the evidence of ranges walked during 
6MWT on a dialysis day. A 6MWD of 300 or less indicates a poor prognosis (“ATS Statement,” 
2002). Since the distance walked before and after dialysis is less than 300 meters in this study, this 
finding suggests that the sample in our study had a poor prognosis. However, a future study with 
walk test performed on dialysis and non-dialysis day might provide more information about 
prognosis in this population. 
  Individuals who reported ‘no fatigue’ walked further compared to individuals who 
reported ‘fatigue present.’ However, no significant difference was observed before and after 
dialysis based on subjective fatigue levels. The number of patients with ‘no fatigue’ was small; 8 
pre-dialysis and 12 post-dialysis. No previous studies have compared 6-minute walk distance 
(6MWD) with subjective fatigue levels. In this study, a significant correlation was obtained 
between total raw score derived from PFS and 6MWD post-dialysis, but the relationship was not 
significant pre-dialysis. The correlation between 6-minute walk and subjective fatigue could be 
due to the ‘physical fatigue’ described as ‘feelings of being washed out and lifelessness’ presenting 
in the post-dialysis period. Since there was no correlation between pre-dialysis PFS and 6MWD, 
it could be stated that the pre-dialysis fatigue may not have physical symptoms compared to the 
post-dialysis session.  
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The mean 6MWD covered was significantly lower in this study when compared to healthy 
subjects from seven different countries (Casanova et al., 2011). This finding signifies that subjects 
on dialysis have significantly reduced physical functional ability (Roshanravan et al., 2013; Torino 
et al., 2014).  A review by Kosmadakis and colleagues (2010) suggested decline of physical 
activity by 3.4% every month after initiation of dialysis in patients. There is a catabolic state 
associated with hemodialysis leading to protein catabolism and degradation, and skeletal muscles 
start getting wasted away. The transport of amino acids to the muscle to generate force does not 
happen appropriately. Mitochondria, the power house of a cell are not able to metabolize energy 
the same way as before. Furthermore, the release of inflammatory markers such as IL-6 lead to a 
muscle wasting and affect physical function (Kosmadakis et al., 2010). 
Aim 2: Identify the extent to which select physiological factors such as anemia, dialysis 
adequacy, inter-dialytic weight gain, co-morbidities, and age influence fatigue severity in 
individuals with Stage G5 CKD on HD. 
In this study, the correlation between hemoglobin values and fatigue scores was weak and 
inverse in the pre-dialysis period and was statistically significant, which means that the higher 
hemoglobin levels were associated with lower fatigue scores. Among the physiological factors, 
hemoglobin was a significant predictor of fatigue severity pre-dialysis. Please note that the 
hemoglobin values were not done on the same day when interviews and fatigue assessment was 
done. The dialysis clinic performed hemoglobin checks every two weeks routinely, and in this 
current study we collected information about hemoglobin values from the medical records of the 
patient. 
The relationship between hemoglobin values and fatigue scores in the post-dialysis period 
was not statistically significant. Most of the previous studies have reported similar findings. These 
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studies did not find a statistical correlation between total fatigue scores and anemia (Biniaz et al., 
2013; Bossola et al., 2018; Chilcot et al., 2016). However, Karakan (2011) found that sensory 
fatigue was correlated with hemoglobin levels (Karakan et al., 2011). Weak and lack of 
relationship could be due to the erythropoietin therapy treatment that patients on dialysis are 
usually on to achieve a target hemoglobin level. Homogeneity of treated hemoglobin values may 
be leading to a weak relationship. 
The correlation between dialysis adequacy and fatigue severity score was not significant 
in the pre or post-dialysis period, however, was trending towards statistical significance. Dialysis 
adequacy was a significant predictor of fatigue pre-dialysis. In a study by Bossola and colleagues 
(2018), post-dialysis fatigue was not associated with dialysis adequacy indicator, Kt/V. The 
present study did not see a relationship, which could be due to all patients being treated to achieve 
adequate Kt/V according to the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines. 
Also, in the present study, fatigue assessment was done on a different day than the day set for 
laboratory blood collection. It could be interesting to see if these relationships would be significant 
if laboratory analyses were done on the same day of interview. This is an area for further 
exploration. This study had insufficient funding to offset laboratory costs. 
In this study, there was no statistically significant difference between the mean interdialytic 
weight gains and fatigue severity. Our findings are similar to Bossola and colleagues (2018), who 
did not find an association between interdialytic weight gain and post-dialysis fatigue. 
No correlation was found between comorbidity scores and fatigue pre and post-dialysis. But, 
based on the PROMIS questionnaire, the correlation between pre-dialysis fatigue score and 
comorbidity score was statistically significant, which means that higher the comorbidities, the 
higher the intensity of fatigue. Contrasting findings have been reported by some investigators, in 
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that post dialysis fatigue was not associated with comorbidity (Bossola et al., 2018; Chilcot et al., 
2016). However, Wang and colleagues (2016) reported a significant association between 
comorbidity and fatigue scores. Patients who have severe comorbidities might be requiring more 
frequent hospital visits and hospitalizations, that might be causing financial and emotional stress 
to the individual impacting fatigue severity. 
There was a significant but weak and inverse correlation between age and fatigue severity 
scores pre and post-dialysis in this study. Age was a significant predictor of fatigue severity before 
and after dialysis. Younger age was associated with higher fatigue scores. This is an interesting 
finding as most investigators have reported higher fatigue levels in older age groups (Karakan et 
al., 2011). The physiological changes that occur in elderly people causes them to be more fatigued 
compared to younger patients (Zyga et al., 2015).Some investigators have reported no association 
between age and fatigue (Jhamb et al., 2009; Zyga et al., 2015). In the present study, no interaction 
was reported between age and race. However, the current study had 36% people who were African 
Americans and were less than 65 years of age. Perhaps, young patients probably had some racial 
differences that led to greater fatigue levels.  
Aim 3: Identify the extent to which select situational factors such as living status, 
employment, gender, and race influence fatigue severity in individuals with Stage G5 CKD 
on HD. 
Pre-dialysis people who ‘lived with someone’ had more fatigue compared to people who 
‘lived alone.’ However, post-dialysis fatigue was similar in both the groups. Perhaps, people who 
‘lived with someone’ are burdened with care of their spouse and children, and this perception 
might be impacting their fatigue levels. 
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In terms of employment, people who were ‘not working’ reported similar fatigue severity 
compared to people who were ‘working.’ However, in this study there were more people who were 
‘retired.’ Perhaps, a study with more subjects who are ‘working’ may yield a significant 
association between the two variables. Contrasting findings were reported by Karakan (2011), in 
that fatigue score was correlated with employment status (Karakan et al., 2011). Biniaz and 
colleagues (2013) reported that employed patients were less fatigued than unemployed, or retired 
patients. Employed patients have more physical activity, adequate social relations and may get 
support from colleagues and friends (Biniaz et al., 2013). 
According to Chi-square analysis, males and females reported similar fatigue severity in 
pre and post-dialysis period. In the current study, 26.7% males reported moderate fatigue 
compared to 22% females who were moderately fatigued pre-dialysis. Post-dialysis 18.5% males 
were moderately fatigued, and 13.6% females were moderately fatigued. However, the Chi-square 
was not significant. On performing a logistic regression to study the influence of situational factors 
on fatigue severity, none of the situational factors were significant predictors. However, gender 
was trending towards significance. Males were more likely to be fatigued severely compared to 
females in the pre-dialysis and post-dialysis period. Some investigators have denied any 
relationship between fatigue and gender (Biniaz et al., 2013; Zyga et al., 2015) whereas some have 
found significant relationship. Most report that women report being more fatigued than men. It has 
been suggested that this may be because women express their feelings/illnesses whereas men see 
illness as a loss of power (Artom et al., 2014; Zyga et al., 2015). Therefore, fatigue is underreported 
by men in many cultures (Biniaz et al., 2013). Perhaps, the culture in U.S. population is different 
than other cultures and could be moderating the relationship between fatigue and gender. 
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In terms of race, African Americans and non-African Americans reported similar fatigue 
severity. Jhamb and colleagues (2009) reported that African Americans had higher energy levels 
compared to non-African Americans. Perhaps, African Americans on dialysis are spiritually 
stronger and may not perceive their illness as a burden (Jhamb et al., 2009). However, the current 
study could not illustrate a relationship between race and fatigue. 
Conformation of Findings with Theoretical Framework 
This study has confirmed and refuted some of the relationships from theory of unpleasant 
symptoms (Lenz & Pugh, 2018). The two constructs that were studied are: Symptoms and 
influencing factors. Findings from the current study have been organized into the following 
sections. 
Symptoms 
 Fatigue, as a single symptom was examined in patients on chronic dialysis. This study 
supports the proposition from TOUS that a ‘symptom has various dimensions.’ This study 
examined the types of fatigue, severity of different fatigue types, overall severity and frequency of 
fatigue. Based on PROMIS-fatigue, participants had higher fatigue levels compared to the general 
U.S. population, patients with cancer and rheumatoid arthritis (Broderick et al., 2013; Cella et al., 
2016). Nearly all of the patients were fatigued pre-dialysis whereas most of the patients were 
fatigued post-dialysis. The proportion of patients in the severely fatigued category increased from 
10% to 24%. Tiredness was reported by 77% of patients on hemodialysis in a study by Jablonski 
(2007) who used TOUS as a framework (Jablonski, 2007). In the current study with regard to the 
frequency of fatigue, most patients said they were fatigued ‘sometimes’ and ‘often’ in the past 1 
week.  Jablonski (2007) reported similar findings in relation to the frequency of fatigue, in that 
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muscle weakness was the most ‘frequently occurring’ symptom and was present ‘most’ of the 
days. 
Different sub-types of fatigue exist such as sensory, affective, behavioral, cognitive and 
motor fatigue. These different types describe the quality of fatigue consistent with TOUS. Most 
patients on dialysis suffered from ‘affective fatigue’ before and after dialysis, and ‘sensory fatigue’ 
was more frequent post-dialysis. Very few patients complained of cognitive fatigue. Motor fatigue 
causes reduced physical function, and patients walked less far after dialysis than they did pre-
dialysis.  
Influencing Factors 
Factors are classified to physiological and situational factors that influence fatigue and its 
dimensions. 
 Physiological factors. Four from the five physiological factors were associated with 
fatigue severity pre-dialysis, whereas one physiological factor was associated with fatigue severity 
post-dialysis. Age was correlated weakly to fatigue severity pre and post-dialysis. Age, dialysis 
adequacy, and hemoglobin predicted fatigue severity pre-dialysis significantly. After dialysis, age 
predicted fatigue severity significantly. Hemoglobin values and dialysis adequacy were correlated 
with fatigue severity in the pre-dialysis period. Comorbidities were associated with PROMIS 
fatigue pre-dialysis. In summary, our study supports the proposition from TOUS that ‘influencing 
factors affect a particular symptom and its dimension’ in pre-dialysis, not in the post-dialysis 
period. Mc Cann and Boore (2000) did not find any significant association between physiological 
factors such as hemoglobin, dialysis adequacy, other laboratory tests, gender with fatigue severity 
in 39 subjects on HD. The subjects however, in that study differed as they had all subjects below 
65 years of age.  In that study, an interaction was noted between physiological and situational 
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factors (McCann & Boore, 2000). The current study did not find an interaction between 
physiological factor, age and situational factor, race. The other major difference to be noted is that 
there was no real-time fatigue measurement in that study, and patients were given questionnaires 
to be filled at home irrespective to the timing of dialysis. Such a measurement could have recall 
bias unlike the current study where we used real-time methods to study fatigue. Almutary and 
colleagues (2017) noted that age and comorbidities were important predictors of ‘symptom 
experience’ as a part of the structural equation model in patients on dialysis. 
Situational factors. Among the situational factors, more people living with someone 
reported fatigue pre-dialysis compared to people who were living alone based on Chi-square 
analysis. Gender, race, living status and employment were not associated with fatigue pre and post 
dialysis based on logistic regression. To summarize, our study did not support TOUS propositions 
as confirmed by McCann and Boore (2000). In that study, they did not find association between 
situational factors such as marital status, employment status, years on dialysis and fatigue 
presence. The influencing factor, gender was dropped from the structural equation model in 
another study done on 423 subjects on HD (Almutary, Douglas, & Bonner, 2017). Thus, it could 
be stated that situational factors do not play an important role in influencing fatigue severity. To 
be noted, most studies in the past have collected information about marital status, and the current 
study examined ‘living status’ for the first time in dialysis subjects. Also, we did not have a 
powered sample for doing a logistic regression in this study.  
From the findings of our study, TOUS was able to describe dimensions of symptom 
‘fatigue.’ TOUS provided minimal confirmation in terms of predicting fatigue symptom 
dimensions. However, other studies have noticed an important role of ‘psychological factors’ in 
predicting fatigue in dialysis (Almutary et al., 2017; McCann & Boore, 2000). The current study 
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did not examine ‘psychological factors’ and therefore, a final comment on the predictive ability of 
TOUS is not possible at this time. Also, a future study with enough power may be helpful in 
commenting on the predictive ability of TOUS. 
Clinical Implications 
Clinical Practice 
This study found a high prevalence of fatigued individuals pre-dialysis and post-dialysis. 
Assessment of fatigue is important and must be taught to nurses, doctors and families caring for 
individuals with CKD and HD. Subjective questionnaires such as PFS are a great way to assess 
fatigue. At the same time, the 6MWT is a safe, and effective way to assess and trend physical or 
motor fatigue. 
This study found high fatigue levels in individuals less than 65 years of age who lived with 
someone. This signifies people who live with someone need to be assessed for fatigue severity. 
Social support could be provided to individuals on HD who are burdened with care of spouses and 
families. Caregivers and family members can be instructed not to burden the patient on fatigue 
days. ‘Psychosocial counselling’ interventions that counsels a patient regarding energy 
distribution, improving physical activity, sleep hygiene practices can be helpful in reducing their 
fatigue levels (Ju, Strippoli, et al., 2018; Van Der Borg, Schipper, & Abma, 2016). 
Physiological factors play a role in increasing fatigue levels. Especially, individuals with 
anemia and inadequate dialysis who need to be identified and treated accordingly. Patients with 
anemia can be treated with erythropoietin injections whereas for inadequate dialysis patients may 
be considered for dialysis with a higher dialysate flow rate (Cha & Min, 2016). Some investigators 
suggest lowering the dialysate temperatures also called cold dialysis to improve post-dialysis 
fatigue (Sajadi, Gholami, Hekmatpour, Soltani, & Haghverdi, 2016), however this intervention 
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needs further exploration (Azar, 2009). Sajadi and colleagues (2016) reported a significant 31% 
reduction in fatigue in a group of patients on HD who were cold dialyzed. Nocturnal (Bugeja et 
al., 2009) or daily dialysis (Jaber et al., 2010; Ray, 2010) may have effect on post-dialysis fatigue. 
Patients on HD were moderately fatigued before and after dialysis, with an increase in 
fatigue post-dialysis. Taking rest for few hours before patient comes in for a dialysis session and 
after session concludes could be a testable strategy. Some clinicians advise patients to keep a diary 
of activities that require most energy, and accordingly prioritizing those activities that are less 
energy demanding around the dialysis treatment may be helpful in managing fatigue (Goudsmit, 
Nijs, Jason, & Wallman, 2012). Strategies can be discussed with participants on how to cope with 
fatigue periods. Brochures and self-help groups based on fatigue assessment could be helpful in 
patients with high risk for developing fatigue, which is nearly all patients on HD (Mohamed, 2014). 
Improving levels of physical activity (Sheshadri, Kittiskulnam, & Johansen, 2018), 
complimentary therapies such as tai-chi (Zhang Y et al., 2013), acupressure (Sabouhi, Kalani, 
Valiani, Mortazavi, & Bemanian, 2013), foot reflexology could be considered for patients with 
high fatigue levels (Unal & Balci Akpinar, 2016). Cognitive behavior therapy is another treatment 
being tested in dialysis population and involves modification of distorted thoughts, emotions and 
behavior. This therapy may help in reducing fatigue levels (Picariello, Moss-Morris, Macdougall, 
Norton, et al., 2018).  
Medications such as levocarnitine, human growth hormone and serum albumin infusion 
may help in reducing fatigue in dialysis population through various mechanisms. However, these 
medications needs further investigation (Jhamb et al., 2008; Ju, Strippoli, et al., 2018). 
Clinical Education   
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Based on the findings that there is a high prevalence of fatigue, it is imperative to educate 
nurses about fatigue in patients on dialysis. Information can be incorporated from this study in 
undergraduate and graduate level curricula. Nurses can be taught through continuing education or 
primary education on topics such as measures for fatigue assessment, influencing factors of 
fatigue, and use of the 6-minute walk test in fatigue assessment. Educational programs could 
include strategies for alleviating fatigue, and the impact of fatigue on health. Content addressing 
impact of fatigue on health and quality of life must be included to create awareness among nurses 
about the importance of fatigue assessment and alleviation in dialysis population. It is not only 
important to educate nurses and staff, but also to provide education to patients and families.  
Research Implications 
Measures need to be identified that study multidimensional aspects of fatigue. Existing 
measures of fatigue are limited by their unidimensionality and scarcity of validating studies. More 
research is needed to validate existing multidimensional measures for assessment of fatigue in 
individuals on HD. Objective measures such as the 6-minute walk test is an excellent measure to 
assess physical fatigue. More research is required to validate the use of 6-minute walk in dialysis 
population. A 6MWT conducted on dialysis versus non-dialysis day can provide information about 
physical fatigue on non-treatment days. A 6MWT conducted four times a day on a treatment as 
well as non-treatment day may be also helpful in getting real-time data about a person’s physical 
fatigue levels. 
More studies on different patterns of fatigue such as continuous fatigue and acute fatigue, 
in dialysis are needed that utilize real-time methods such as 6-minute walk test, and ecological 
momentary assessment. Following a patient after dialysis and through the non-dialysis day until 
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the person goes for the next dialysis session could open new findings about fatigue and factors that 
influence it.  
The current study had more retired individuals compared to individuals who were working. 
Most of the working individuals were not interested in the study as they had to rush for work after 
dialysis finishes and could not wait for study purposes. A working sample may have different 
findings on fatigue and could be studied further in a larger group of patients. Utilizing phone-based 
applications for fatigue assessment might be another strategy for this group of people. However, 
in that case other factors such as literacy level must be considered while using phone-based 
application in this population. 
This study showed some of the physiological factors predicting fatigue levels. There are 
more clinical parameters that this study could not include due to modest funding and grant 
timelines. Studies finding relationship with other physiological factors like albumin, C-reactive 
protein, and sleep problems are needed.  
This study did not study psychological factors such as depression, anxiety and social 
support. Psychological factors may significantly predict fatigue in dialysis and requires further 
exploration. 
Since patients suffer from cognitive, behavioral and affective fatigue, psychological 
interventions like Cognitive Behavior Therapy may be a helpful intervention in patients suffering 
from fatigue in dialysis. More research is needed in this regard. 
The majority of the subjects in this study were retired and had severe comorbidities. The 
6-minute walk test could be studied in a type of dialysis population who are employed and has 
fewer co-morbidities.  
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Strengths of the Study 
This study has used the PROMIS measures for fatigue assessment using computer 
administration method in Redcap software, thereby contributing towards NIH goal of using this 
measure across various diseases.  We utilized this measure in a dialysis population that consisted 
of retired individuals, who are not usually considered computer-savvy.  
The current study utilized PFS-12, a modified version of PFS for the first time in dialysis 
population. Studies that have utilized PFS in dialysis administered the measure after dialysis 
(Karakan et al., 2011). Our study measured fatigue before and after dialysis.  
This study had 6-minute walk test conducted in the pre and post-dialysis sessions, which 
provides a real-time assessment of fatigue as opposed to other studies that have performed 6-
minute walk test on a non-dialysis day or have measured physical performance.  
This study reports the reliability of PROMIS-CAT fatigue and PFS-12; that conforms the 
robustness of these measures and has a potential to be used in future studies for assessment of 
fatigue. 
This study has findings from multi-sites with real time assessment of fatigue before and 
after dialysis, that increases the generalizability of the findings. Almost all studies on fatigue have 
utilized self-report measures in the past. This study uses a combination of self-report and objective 
measures like 6-minute walk test that increases the validity of our findings. This study has an 
ethnically-diverse powered sample and findings may be attributable to bigger population with 
diversity. 
Limitations of the Study 
Convenience sampling was used and therefore, the findings may not be generalizable to a 
bigger population. We could not collect data from individuals who were dropped or declined from 
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the study to examine significant differences of subjects based on age, weight gain, and race. More 
subjects could be enrolled with greater funding and hiring research assistants from a bigger team 
that the present study could not achieve. The laboratory collection was not done on the same day 
of interview and walk test due to modest funding. Laboratory collection on the same day may have 
resulted in achieving significant findings with physiological factors.  
We had a higher consent declination rate from one of the sites, which could be due to the 
principal investigator (who obtained consent) being seen an ‘outsider’ by many of the patients. 
The consent rates may be higher if a site personnel obtains informed consent from the subjects. 
Some of the findings from regression did not achieve significance due to inadequate sample size 
in the study based on the post-hoc power analysis. A future study with enough power may be 
helpful.  
Summary 
Fatigue is a ubiquitous symptom in majority of the chronic diseases, and currently one of 
the research priorities in NINR. This study examined fatigue in 86 patients on chronic dialysis 
from various dialysis centers in Michigan. The multiple dimensions of fatigue were examined 
using multidimensional subjective measures such as Piper Fatigue Scale and PROMIS-fatigue, 
along with one objective measure, the six-minute walk test. Some of these measures have never 
been utilized in the dialysis population. Nearly all the patients had fatigue, with most patients 
suffering from affective fatigue pre and post dialysis; and sensory fatigue post-dialysis. This study 
examined various physiological and situational factors that influenced fatigue severity in this 
dialysis population. Among these factors, dialysis adequacy, age, hemoglobin, comorbidity and 
living status were associated with fatigue severity. Thus, this study has advanced knowledge about 
the prevalence and dimensions of fatigue, and the underlying factors that influence fatigue in 
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dialysis population. A better understanding of symptoms such as fatigue may eventually help in 
better management of chronic kidney disease and contribute to a better quality of life in this 
population.  
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ABSTRACT 
MULTIPLE DIMENSIONS AND CORRELATES OF FATIGUE IN INDIVIDUALS ON 
HEMODIALYSIS: A QUANTITATIVE STUDY 
by 
BINCY JOSHWA 
May 2019 
Advisor: Dr. Margaret L. Campbell 
Major: Nursing 
Degree: Doctor of Philosophy 
Background: Fatigue is present in individuals on Hemodialysis (HD). Evidence on fatigue 
in HD are limited by focus on unidimensional aspect of fatigue, flawed unidimensional tools, lack 
of objective measures, and variability in the correlates of fatigue. Purpose: To examine severity 
and trajectory pattern of fatigue; delineate influencing physiological and situational factors pre-
dialysis and post-dialysis. Theoretical Framework: The Theory of Unpleasant Symptoms was 
used to guide the study. Methodology: A descriptive, correlational, before-after design was 
utilized. Measures were Piper Fatigue Scale (PFS)-12, Patient Reported Outcomes Measurement 
Information Systems (PROMIS)-Fatigue, Charlson Comorbidity Index and six-minute walk test 
(6MWT). Adults, cognitively intact patients on HD were included; patients with limited mobility, 
heart issues and abnormal vital signs were excluded for the 6MWT. Results: Sample was 86 
participants, 24-89 years old, 58.1% males, and 51.1% non-whites. In terms of prevalence, 90% 
of the patients were fatigued pre-dialysis whereas 85% of the patients were fatigued post-dialysis. 
Most individuals were moderately fatigued pre-dialysis and most were mildly and moderately 
fatigued post-dialysis. The mean scores of fatigue based on PFS-12 increased after dialysis, 
however, no statistical difference was observed. In terms of quality of fatigue, high ‘affective 
155 
 
 
fatigue’ mean scores were reported before and after dialysis session. An increase in sensory and 
cognitive fatigue was observed from pre-dialysis to the post-dialysis period. In terms of 
frequency,70% patients said that they had fatigue ‘often’ or ‘sometimes’ in the past 7 days. The 
mean PROMIS fatigue score was significantly higher than average U.S. population. Individuals 
walked significantly further during 6-minute walk test pre-dialysis than post-dialysis, that indicates 
patients are physically fatigued. Fatigue was severe in individuals with low hemoglobin values, 
inadequate dialysis, comorbidities, young age group and individuals who lived with someone. 
Conclusion: Prevalence of fatigue is higher in dialysis than general population, and fatigue 
escalates after dialysis. Therapies that can target sensory, cognitive and physical fatigue may be 
helpful in alleviation of fatigue in these patients. A better understanding of fatigue will eventually 
help in better management of chronic kidney disease and contribute to a better quality of life in 
this population.  
  
156 
 
 
AUTOBIOGRAPHICAL STATEMENT 
Bincy Joshwa is a symptom scientist whose research focuses on fatigue. She has completed 
her bachelor’s in nursing and master’s in nephrology nursing from All India Institute of Medical 
Sciences, India. Her education in nephrology nursing initiated her interest in individuals with 
kidney failure and dialysis. Findings from her first study on patients on dialysis found a high 
prevalence of multiple symptoms such as sleep, fatigue and depression. Her doctoral dissertation 
study focused on fatigue specifically, its multiple dimensions and correlates. She received various 
fellowships, awards and research grants in her program of study. She has taught various levels of 
graduate nurses and brings expertise from her clinical background working as a nurse with 
medical-surgical and dialysis patients. 
 
